≡ Risteys
R14

Documentation Changelog GitHub Contact & Feedback

Other congenital malformations of integument, including avohilmo

Endpoint Browser PheWeb

Q17_OTHER_CONGEN_MALFO_INTEG_WIDE

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps

FinnGen

Phenotype data

519870

1. Apply sex-specific rule

None

519870

2. Check conditions

None

519870

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Primary healthcare outpatient: ICD-10 — Q84
  • Hospital discharge: ICD-10 — Q84
  • Cause of death: ICD-10 — Q84

3 out of 7 registries used, show all original rules.

119

4. Check minimum number of events

None

119

5. Include endpoints

None

119

6. Filter based on genotype QC (FinnGen only)

113

Control definitions (FinnGen only)

Control exclude
Q17_OTHER_CONGEN_MALFO

Extra metadata

Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF13
Parent code in ICD-10
Q8
Name in latin
Aliae malformationes congenitae integumenti communis

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded (different definition than used in FinnGen).

-FinnGen-

Key figures

All Female Male
Number of individuals 113 59 54
Unadjusted period prevalence (%) 0.02 0.02 0.02
Median age at first event (years) 61.67 59.49 64.05

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
119
Matched controls
1190
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
Q84.5
ICD-10 Finland
Enlarged and hypertrophic nails
+∞
90.5
75
*
XCK10
NOMESCO Finland
Photography of fundus of eye
6.9
19.1
36
70
Z3226
NOMESCO Finland
Physiotherapist
4.3
12.9
46
151
L60
ICD-10 Finland
Nail disorders
78.5
12.9
14
*
R4110
NOMESCO Finland
Physiotherapy
4.0
12.4
58
230
E11
ICD-10 Finland
Type 2 diabetes mellitus
4.6
12.0
36
103
L84
ICD-10 Finland
Corns and callosities
13.9
11.9
20
17
Z71.2
ICD-10 Finland
Person consulting for explanation of investigation findings
3.7
11.5
62
268
Z2221
NOMESCO Finland
Medical doctor
3.8
11.3
54
215
L97
ICD-10 Finland
Ulcer of lower limb, not elsewhere classified
12.3
10.7
19
18
A28
ICPC
Limited function/disability NOS
4.0
10.6
39
129
Q84.9
ICD-10 Finland
Congenital malformation of integument, unspecified
+∞
10.6
10
*
Q84.6
ICD-10 Finland
Other congenital malformations of nails
+∞
10.6
10
*
B35.1
ICD-10 Finland
Tinea unguium
5.6
10.5
22
46
ZXE10
NOMESCO Finland
More than one and less than three hours
3.5
10.3
62
283
L60.3
ICD-10 Finland
Nail dystrophy
108.3
9.6
10
*
Q84.8
ICD-10 Finland
Other specified congenital malformations of integument
+∞
9.5
9
*
R5110, ,
SPAT
4.8
9.0
23
57
Z01.0
ICD-10 Finland
Examination of eyes and vision
3.6
8.8
37
133
I50
ICD-10 Finland
Heart failure
12.1
8.6
15
14
Z01.7
ICD-10 Finland
Laboratory examination
3.5
8.5
37
135
Z3231
NOMESCO Finland
Registered nurse
3.1
8.0
51
234
L17
ICPC
Foot/toe symptom/complaint
3.0
7.8
56
274
ZXE00
NOMESCO Finland
One hour or less
2.9
7.6
62
323
ZXD10
NOMESCO Finland
Scheduled procedure
2.9
7.6
58
293
L60.0
ICD-10 Finland
Ingrowing nail
6.9
7.1
17
28
Z71.8
ICD-10 Finland
Other specified counselling
2.8
7.0
55
279
PG1DE
NOMESCO Finland
Other extensive ultrasound examination of artery
8.7
6.8
14
18
WX002
NOMESCO Finland
Sedation and analgesia
3.1
6.8
35
140
Z01.6
ICD-10 Finland
Radiological examination, not elsewhere classified
3.9
6.8
22
65
A46
ICD-10 Finland
Erysipelas
3.3
6.6
30
111
ZXD35
NOMESCO Finland
Usual procedure
8.2
6.6
14
19
WX892
NOMESCO Finland
Monitored bed care
4.3
6.2
17
44
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
3.1
6.2
31
122
Z76.0
ICD-10 Finland
Issue of repeat prescription
2.7
6.1
46
225

TimeCodeWAS

↥

TODO / Current known limitations:

  • Only showing the top 300 codes, because showing all (sometimes 20k) makes the page too slow.
  • Legend / how to read the glyphs.
  • Show details (e.g. Fisher or Chi-square test, LR+, etc.) when clicking on a row.
  • Explanation on the underlying data / how the TimeCodeWAS is done (e.g. matched cases / controls, eligibility).
  • Download CSV.
  • No filters and sorters.
  • Limited amount of endpoints (~400) having TimeCodeWAS data.
  • Cross-links to Risteys lab test pages for lab test codes.
OMOP concept
ln(OR)
%cases with code / %controls with code
2×2 table
Photography of fundus of eye
XCK10 [2001301381]
2.3e+00
2.6e+00
—
—
—
2.0e+00
2.7e+00
cases:23.42%
controls:2.88%
cases:13.39%
controls:1.08%
—
—
—
—
—
—
cases:7.41%
controls:1.12%
cases:26.67%
controls:2.37%
26
32
85
1078
15
12
97
1103
—
—
—
8
12
100
1063
24
21
66
864
Type 2 diabetes mellitus
E11 [45571656]
1.5e+00
1.6e+00
2.5e+00
1.0e+50
—
1.8e+00
1.7e+00
cases:23.42%
controls:6.22%
cases:16.96%
controls:4.13%
cases:8.04%
controls:0.72%
cases:16.96%
controls:0.00%
—
—
cases:18.52%
controls:3.72%
cases:34.44%
controls:8.47%
26
69
85
1041
19
46
93
1069
9
8
103
1107
19
0
93
1115
—
20
40
88
1035
31
75
59
810
Physiotherapist
Z3226 [2001311560]
1.6e+00
2.4e+00
—
—
—
2.5e+00
2.0e+00
cases:17.12%
controls:3.87%
cases:8.93%
controls:0.90%
—
—
—
—
—
—
cases:6.48%
controls:0.56%
cases:13.33%
controls:2.03%
19
43
92
1067
10
10
102
1105
—
—
—
7
6
101
1069
12
18
78
867
Telehealth
OMOP5556618 [722455]
7.5e-01
1.2e+00
1.8e+00
—
1.4e+00
1.4e+00
1.2e+00
cases:36.04%
controls:21.08%
cases:31.25%
controls:12.02%
cases:11.61%
controls:2.15%
—
—
cases:8.93%
controls:2.25%
cases:39.81%
controls:13.67%
cases:62.22%
controls:33.11%
40
234
71
876
35
134
77
981
13
24
99
1091
—
10
25
102
1088
43
147
65
928
56
293
34
592
Case Management Agency
251B00000X [38004193]
4.6e-01
6.7e-01
9.3e-01
5.2e+00
1.1e+00
6.2e-01
8.0e-01
cases:76.58%
controls:67.30%
cases:79.46%
controls:66.46%
cases:45.54%
controls:24.84%
cases:76.79%
controls:1.79%
cases:48.21%
controls:24.35%
cases:80.56%
controls:69.12%
cases:93.33%
controls:86.33%
85
747
26
363
89
741
23
374
51
277
61
838
86
20
26
1095
54
271
58
842
87
743
21
332
84
764
6
121
Medical doctor
Z2221 [2001311556]
2.0e+00
1.8e+00
—
—
—
1.8e+00
1.5e+00
cases:32.43%
controls:6.04%
cases:14.29%
controls:2.78%
—
—
—
—
—
—
cases:14.81%
controls:2.88%
cases:18.89%
controls:5.08%
36
67
75
1043
16
31
96
1084
—
—
—
16
31
92
1044
17
45
73
840
warfarin; oral, parenteral
B01AA03 [21600965]
1.1e+00
1.1e+00
1.8e+00
—
1.6e+00
1.1e+00
1.2e+00
cases:16.22%
controls:6.13%
cases:14.29%
controls:5.20%
cases:7.14%
controls:1.26%
—
—
cases:5.36%
controls:1.17%
cases:15.74%
controls:5.67%
cases:21.11%
controls:7.57%
18
68
93
1042
16
58
96
1057
8
14
104
1101
—
6
13
106
1100
17
61
91
1014
19
67
71
818
Outpatient Visit
OP [9202]
9.8e-01
1.0e+00
3.4e-01
3.8e+00
6.7e-01
1.3e+00
7.1e-01
cases:88.29%
controls:73.87%
cases:76.79%
controls:53.81%
cases:16.07%
controls:12.02%
cases:16.96%
controls:0.45%
cases:20.54%
controls:11.68%
cases:78.70%
controls:51.07%
cases:91.11%
controls:83.39%
98
820
13
290
86
600
26
515
18
134
94
981
19
5
93
1110
23
130
89
983
85
549
23
526
82
738
8
147
Supplier / Service Provider
OMOP5117446 [33004]
-3.2e-01
—
-1.0e+50
—
—
2.5e+00
3.2e+00
cases:17.12%
controls:22.07%
—
—
cases:0.00%
controls:0.63%
—
—
—
—
cases:6.48%
controls:0.56%
cases:27.78%
controls:1.47%
19
245
92
865
—
0
7
112
1108
—
—
7
6
101
1069
25
13
65
872
Physiotherapy
R4110 [2001310233]
1.6e+00
1.4e+00
—
—
—
1.9e+00
1.6e+00
cases:18.92%
controls:4.50%
cases:8.93%
controls:2.42%
—
—
—
—
—
—
cases:6.48%
controls:1.02%
cases:21.11%
controls:5.20%
21
50
90
1060
10
27
102
1088
—
—
—
7
11
101
1064
19
46
71
839
Scheduled procedure
ZXD10 [2001311387]
1.4e+00
1.3e+00
—
—
—
1.7e+00
1.6e+00
cases:18.02%
controls:4.95%
cases:7.14%
controls:2.06%
—
—
—
—
—
—
cases:7.41%
controls:1.49%
cases:24.44%
controls:5.99%
20
55
91
1055
8
23
104
1092
—
—
—
8
16
100
1059
22
53
68
832
metformin; oral
A10BA02 [21600747]
1.3e+00
1.0e+00
4.0e-01
—
1.0e+00
9.1e-01
1.0e+00
cases:27.93%
controls:9.28%
cases:21.43%
controls:8.79%
cases:4.46%
controls:3.05%
—
—
cases:7.14%
controls:2.70%
cases:21.30%
controls:9.86%
cases:27.78%
controls:12.43%
31
103
80
1007
24
98
88
1017
5
34
107
1081
—
8
30
104
1083
23
106
85
969
25
110
65
775
Pharmacy visit
OMOP4822462 [581458]
1.2e+00
5.2e-01
4.3e-01
1.5e+00
4.6e-01
2.6e+00
1.0e+50
cases:99.10%
controls:96.94%
cases:92.86%
controls:88.52%
cases:62.50%
controls:52.11%
cases:9.82%
controls:2.42%
cases:63.39%
controls:52.11%
cases:99.07%
controls:88.47%
cases:100.00%
controls:96.16%
110
1076
1
34
104
987
8
128
70
581
42
534
11
27
101
1088
71
580
41
533
107
951
1
124
90
851
0
34
One hour or less
ZXE00 [2001311394]
1.2e+00
9.9e-01
—
—
—
1.6e+00
1.3e+00
cases:17.12%
controls:6.13%
cases:6.25%
controls:2.42%
—
—
—
—
—
—
cases:8.33%
controls:1.86%
cases:20.00%
controls:6.67%
19
68
92
1042
7
27
105
1088
—
—
—
9
20
99
1055
18
59
72
826
Person consulting for explanation of investigation findings
Z71.2 [45552100]
9.6e-01
1.0e+00
—
—
—
1.7e+00
2.0e+00
cases:10.81%
controls:4.41%
cases:5.36%
controls:1.97%
—
—
—
—
—
—
cases:10.19%
controls:1.95%
cases:28.89%
controls:4.97%
12
49
99
1061
6
22
106
1093
—
—
—
11
21
97
1054
26
44
64
841
Ophthalmology
18 [38004463]
1.3e+00
1.2e+00
1.3e+00
—
—
8.7e-01
1.2e+00
cases:42.34%
controls:16.76%
cases:25.89%
controls:9.51%
cases:6.25%
controls:1.70%
—
—
—
—
cases:17.59%
controls:8.19%
cases:48.89%
controls:21.92%
47
186
64
924
29
106
83
1009
7
19
105
1096
—
—
19
88
89
987
44
194
46
691
Erysipelas
A46 [45561706]
1.5e+00
—
—
—
—
2.0e+00
1.6e+00
cases:6.31%
controls:1.44%
—
—
—
—
—
—
—
—
cases:6.48%
controls:0.93%
cases:10.00%
controls:2.26%
7
16
104
1094
—
—
—
—
7
10
101
1065
9
20
81
865
Internal Medicine
11 [38004456]
1.0e+00
6.2e-01
—
—
—
1.1e+00
1.1e+00
cases:45.95%
controls:23.33%
cases:15.18%
controls:8.79%
—
—
—
—
—
—
cases:25.00%
controls:9.58%
cases:48.89%
controls:24.18%
51
259
60
851
17
98
95
1017
—
—
—
27
103
81
972
44
214
46
671
Heart failure
I50 [45581779]
—
—
—
—
—
—
2.8e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:8.89%
controls:0.56%
—
—
—
—
—
—
8
5
82
880
Neurology
13 [38004458]
6.7e-01
1.0e+00
—
—
—
1.5e+00
1.3e+00
cases:20.72%
controls:11.80%
cases:11.61%
controls:4.57%
—
—
—
—
—
—
cases:15.74%
controls:4.09%
cases:33.33%
controls:11.86%
23
131
88
979
13
51
99
1064
—
—
—
17
44
91
1031
30
105
60
780
Coxarthrosis [arthrosis of hip]
M16 [45577162]
—
—
—
—
—
—
2.7e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:7.78%
controls:0.56%
—
—
—
—
—
—
7
5
83
880
Ulcer of lower limb, not elsewhere classified
L97 [45591659]
—
—
—
—
—
—
2.6e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:12.22%
controls:1.02%
—
—
—
—
—
—
11
9
79
876
FVC percent change Respiratory system
69982-7 [42868471]
1.2e+00
—
—
—
—
—
2.6e+00
cases:5.41%
controls:1.62%
—
—
—
—
—
—
—
—
—
—
cases:14.44%
controls:1.24%
6
18
105
1092
—
—
—
—
—
13
11
77
874
FEV1 --post bronchodilation
20155-8 [3023550]
1.2e+00
—
—
—
—
—
2.6e+00
cases:5.41%
controls:1.62%
—
—
—
—
—
—
—
—
—
—
cases:14.44%
controls:1.24%
6
18
105
1092
—
—
—
—
—
13
11
77
874
FEV1 percent change
69983-5 [42868472]
1.2e+00
—
—
—
—
—
2.6e+00
cases:5.41%
controls:1.62%
—
—
—
—
—
—
—
—
—
—
cases:14.44%
controls:1.24%
6
18
105
1092
—
—
—
—
—
13
11
77
874
FEV1/FVC --post bronchodilation
69970-2 [42868459]
1.2e+00
—
—
—
—
—
2.6e+00
cases:5.41%
controls:1.62%
—
—
—
—
—
—
—
—
—
—
cases:14.44%
controls:1.24%
6
18
105
1092
—
—
—
—
—
13
11
77
874
Forced vital capacity [Volume] Respiratory system --post bronchodilation
19875-4 [3001668]
1.2e+00
—
—
—
—
—
2.6e+00
cases:5.41%
controls:1.62%
—
—
—
—
—
—
—
—
—
—
cases:14.44%
controls:1.24%
6
18
105
1092
—
—
—
—
—
13
11
77
874
More than one and less than three hours
ZXE10 [2001311401]
1.2e+00
—
—
—
—
1.4e+00
1.3e+00
cases:18.02%
controls:6.13%
—
—
—
—
—
—
—
—
cases:7.41%
controls:1.95%
cases:20.00%
controls:6.21%
20
68
91
1042
—
—
—
—
8
21
100
1054
18
55
72
830
formoterol, glycopyrronium bromide and budesonide
R03AL11 [715850]
—
—
—
—
—
2.5e+00
—
—
—
—
—
—
—
—
—
—
—
cases:5.56%
controls:0.47%
—
—
—
—
—
—
—
6
5
102
1070
—
Atrial fibrillation and flutter
I48 [45596206]
9.6e-01
1.1e+00
2.5e+00
—
—
9.2e-01
8.7e-01
cases:14.41%
controls:6.04%
cases:9.82%
controls:3.41%
cases:5.36%
controls:0.45%
—
—
—
—
cases:11.11%
controls:4.74%
cases:18.89%
controls:8.93%
16
67
95
1043
11
38
101
1077
6
5
106
1110
—
—
12
51
96
1024
17
79
73
806
FEV1
20150-9 [3024653]
1.4e+00
—
—
—
—
2.2e+00
2.5e+00
cases:6.31%
controls:1.62%
—
—
—
—
—
—
—
—
cases:4.63%
controls:0.56%
cases:15.56%
controls:1.47%
7
18
104
1092
—
—
—
—
5
6
103
1069
14
13
76
872
FEV1/FVC
19926-5 [3011505]
1.4e+00
—
—
—
—
2.2e+00
2.5e+00
cases:6.31%
controls:1.62%
—
—
—
—
—
—
—
—
cases:4.63%
controls:0.56%
cases:15.56%
controls:1.47%
7
18
104
1092
—
—
—
—
5
6
103
1069
14
13
76
872
Forced vital capacity [Volume] Respiratory system
19870-5 [3020158]
1.4e+00
—
—
—
—
2.2e+00
2.5e+00
cases:6.31%
controls:1.62%
—
—
—
—
—
—
—
—
cases:4.63%
controls:0.56%
cases:15.56%
controls:1.47%
7
18
104
1092
—
—
—
—
5
6
103
1069
14
13
76
872
Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
46082-4 [3046524]
—
—
—
—
—
—
2.5e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:8.89%
controls:0.79%
—
—
—
—
—
—
8
7
82
878
Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
46083-2 [3043362]
—
—
—
—
—
—
2.5e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:8.89%
controls:0.79%
—
—
—
—
—
—
8
7
82
878
Acute bronchitis
J20 [45581849]
—
—
—
—
—
—
2.5e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:11.11%
controls:1.02%
—
—
—
—
—
—
10
9
80
876
formoterol and budesonide
R03AK07 [21603281]
—
—
—
—
—
2.3e+00
—
—
—
—
—
—
—
—
—
—
—
cases:5.56%
controls:0.56%
—
—
—
—
—
—
—
6
6
102
1069
—
Other extensive ultrasound examination of artery
PG1DE [2001309713]
—
—
—
—
—
—
2.3e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:6.67%
controls:0.68%
—
—
—
—
—
—
6
6
84
879
Ingrowing nail
L60.0 [45548199]
—
—
—
—
—
—
2.3e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:6.67%
controls:0.68%
—
—
—
—
—
—
6
6
84
879
Shoulder X-ray examination without contrast
NB1AA [2001307225]
2.3e+00
—
—
—
—
—
—
cases:4.50%
controls:0.45%
—
—
—
—
—
—
—
—
—
—
—
—
5
5
106
1105
—
—
—
—
—
—
Bicarbonate [Moles/volume] standard in Arterial blood
19230-2 [3014218]
—
—
—
—
—
—
2.2e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:8.89%
controls:1.02%
—
—
—
—
—
—
8
9
82
876
Influenza virus A+B Ag [Presence] in Specimen
24015-0 [3024891]
—
—
—
—
—
—
2.1e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:7.78%
controls:1.02%
—
—
—
—
—
—
7
9
83
876
Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
1805-1 [3016417]
—
—
—
—
—
—
2.1e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:12.22%
controls:1.69%
—
—
—
—
—
—
11
15
79
870
X-ray examination of the lungs in one projection
GD1PA [2001303645]
2.1e+00
-1.0e+50
—
—
—
-1.0e+50
—
cases:5.41%
controls:0.72%
cases:0.00%
controls:0.72%
—
—
—
—
—
—
cases:0.00%
controls:0.56%
—
—
6
8
105
1102
0
8
112
1107
—
—
—
0
6
108
1069
—
Protein electrophoresis panel - Serum or Plasma
24351-9 [3004588]
2.1e+00
—
—
—
—
—
1.8e+00
cases:5.41%
controls:0.72%
—
—
—
—
—
—
—
—
—
—
cases:6.67%
controls:1.13%
6
8
105
1102
—
—
—
—
—
6
10
84
875
Examination of eyes and vision
Z01.0 [45566391]
—
-1.0e+50
—
—
—
—
2.1e+00
—
—
cases:0.00%
controls:1.70%
—
—
—
—
—
—
—
—
cases:22.22%
controls:3.50%
—
0
19
112
1096
—
—
—
—
20
31
70
854
Plastic And Reconstructive Surgery
24 [38004467]
—
—
—
—
—
2.1e+00
1.2e+00
—
—
—
—
—
—
—
—
—
—
cases:5.56%
controls:0.74%
cases:12.22%
controls:3.95%
—
—
—
—
—
6
8
102
1067
11
35
79
850
In Home Supportive Care Agency
253Z00000X [38004206]
—
-1.0e+50
—
—
—
—
2.1e+00
—
—
cases:0.00%
controls:0.45%
—
—
—
—
—
—
—
—
cases:6.67%
controls:0.90%
—
0
5
112
1110
—
—
—
—
6
8
84
877
mometasone
D07AC13 [21602132]
—
—
—
—
—
2.0e+00
9.5e-01
—
—
—
—
—
—
—
—
—
—
cases:6.48%
controls:0.93%
cases:7.78%
controls:3.16%
—
—
—
—
—
7
10
101
1065
7
28
83
857
Medical observation and evaluation for suspected diseases and conditions, ruled out
Z03 [45552058]
1.9e+00
—
—
—
—
—
2.0e+00
cases:4.50%
controls:0.72%
—
—
—
—
—
—
—
—
—
—
cases:7.78%
controls:1.13%
5
8
106
1102
—
—
—
—
—
7
10
83
875
influenza, inactivated, split virus or surface antigen
J07BB02 [21601335]
6.4e-02
4.9e-01
—
—
—
8.2e-01
1.2e+00
cases:19.82%
controls:18.83%
cases:22.32%
controls:14.98%
—
—
—
—
—
—
cases:26.85%
controls:13.95%
cases:58.89%
controls:30.62%
22
209
89
901
25
167
87
948
—
—
—
29
150
79
925
53
271
37
614
Asthma
J45 [45596282]
8.3e-01
—
—
—
—
—
2.0e+00
cases:5.41%
controls:2.43%
—
—
—
—
—
—
—
—
—
—
cases:15.56%
controls:2.49%
6
27
105
1083
—
—
—
—
—
14
22
76
863
Radiological examination, not elsewhere classified
Z01.6 [45605096]
—
—
—
—
—
—
2.0e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:8.89%
controls:1.36%
—
—
—
—
—
—
8
12
82
873
Doppler ultrasound examination of heart
FM1DE [2001303299]
1.1e+00
—
—
—
—
—
1.9e+00
cases:4.50%
controls:1.62%
—
—
—
—
—
—
—
—
—
—
cases:11.11%
controls:1.81%
5
18
106
1092
—
—
—
—
—
10
16
80
869
Other diagnostic examination of periferal vessel
XPX99 [2001309755]
-1.0e+50
—
—
—
—
—
1.9e+00
cases:0.00%
controls:0.81%
—
—
—
—
—
—
—
—
—
—
cases:7.78%
controls:1.24%
0
9
111
1101
—
—
—
—
—
7
11
83
874
Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
40987-0 [3043924]
—
-1.0e+50
—
—
—
—
1.9e+00
—
—
cases:0.00%
controls:0.54%
—
—
—
—
—
—
—
—
cases:13.33%
controls:2.26%
—
0
6
112
1109
—
—
—
—
12
20
78
865
Erythrocyte [DistWidth] in Red Blood Cells
30385-9 [3002385]
2.1e-01
2.5e-01
7.5e-01
—
1.3e+00
8.2e-01
1.1e+00
cases:23.42%
controls:19.82%
cases:20.54%
controls:16.77%
cases:7.14%
controls:3.50%
—
—
cases:9.82%
controls:2.96%
cases:32.41%
controls:17.40%
cases:66.67%
controls:40.79%
26
220
85
890
23
187
89
928
8
39
104
1076
—
11
33
101
1080
35
187
73
888
60
361
30
524
Infiltration anesthesia
WX110 [2001310767]
2.4e-02
1.9e-01
—
—
1.4e+00
9.4e-01
9.3e-01
cases:18.92%
controls:18.56%
cases:9.82%
controls:8.25%
—
—
—
—
cases:5.36%
controls:1.35%
cases:18.52%
controls:8.19%
cases:47.78%
controls:26.44%
21
206
90
904
11
92
101
1023
—
—
6
15
106
1098
20
88
88
987
43
234
47
651
Outpatient Hospital
22 [8756]
6.1e-01
3.1e-01
—
—
1.4e+00
1.0e+00
8.4e-01
cases:36.94%
controls:24.05%
cases:10.71%
controls:8.07%
—
—
—
—
cases:4.46%
controls:1.17%
cases:18.52%
controls:7.63%
cases:41.11%
controls:23.16%
41
267
70
843
12
90
100
1025
—
—
5
13
107
1100
20
82
88
993
37
205
53
680
Standard cardiac ultrasound examination
FM1AE [2001303278]
1.2e+00
1.5e+00
—
—
—
1.8e+00
1.1e+00
cases:9.01%
controls:2.97%
cases:5.36%
controls:1.26%
—
—
—
—
—
—
cases:7.41%
controls:1.30%
cases:10.00%
controls:3.50%
10
33
101
1077
6
14
106
1101
—
—
—
8
14
100
1061
9
31
81
854
Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
40982-1 [3038288]
—
—
—
—
—
—
1.7e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:12.22%
controls:2.37%
—
—
—
—
—
—
11
21
79
864
glimepiride; oral
A10BB12 [21600761]
1.7e+00
—
—
—
—
—
—
cases:7.21%
controls:1.35%
—
—
—
—
—
—
—
—
—
—
—
—
8
15
103
1095
—
—
—
—
—
—
Deposits [accretions] on teeth betel
K03.65 [2000502690]
8.4e-01
—
—
—
—
2.0e+00
1.7e+00
cases:7.21%
controls:3.24%
—
—
—
—
—
—
—
—
cases:4.63%
controls:0.65%
cases:15.56%
controls:3.16%
8
36
103
1074
—
—
—
—
5
7
103
1068
14
28
76
857
Prothrombin time (PT) actual/Normal
5894-1 [3033658]
—
—
—
—
-1.0e+50
—
1.7e+00
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.45%
—
—
cases:30.00%
controls:7.34%
—
—
—
—
0
5
112
1108
—
27
65
63
820
Thorax X-ray examination outside radiological department
GD1UA [2001303652]
1.7e+00
—
—
—
—
—
—
cases:9.01%
controls:1.80%
—
—
—
—
—
—
—
—
—
—
—
—
10
20
101
1090
—
—
—
—
—
—
Diabetes, non-insulin-treated
215 [2001600211]
—
-1.0e+50
—
—
—
-1.0e+50
1.7e+00
—
—
cases:0.00%
controls:0.99%
—
—
—
—
—
—
cases:0.00%
controls:0.74%
cases:31.11%
controls:7.80%
—
0
11
112
1104
—
—
—
0
8
108
1067
28
69
62
816
Dermatitis, unspecified
L30.9 [45572271]
1.7e+00
—
—
—
—
-1.0e+50
—
cases:8.11%
controls:1.62%
—
—
—
—
—
—
—
—
cases:0.00%
controls:1.12%
—
—
9
18
102
1092
—
—
—
—
0
12
108
1063
—
Localized oedema
R60.0 [45597193]
—
—
—
—
—
—
1.7e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:10.00%
controls:2.03%
—
—
—
—
—
—
9
18
81
867
Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
34487-9 [3044938]
—
-1.0e+50
—
—
—
—
1.6e+00
—
—
cases:0.00%
controls:0.54%
—
—
—
—
—
—
—
—
cases:14.44%
controls:3.39%
—
0
6
112
1109
—
—
—
—
13
30
77
855
Diabetes, insulin-treated
103 [2001600103]
1.5e+00
1.4e+00
—
—
—
-1.0e+50
—
cases:13.51%
controls:3.24%
cases:4.46%
controls:1.17%
—
—
—
—
—
—
cases:0.00%
controls:0.65%
—
—
15
36
96
1074
5
13
107
1102
—
—
—
0
7
108
1068
—
Short blood count panel - Blood
55429-5 [40758558]
2.6e-01
9.9e-01
—
—
—
9.2e-01
1.5e+00
cases:5.41%
controls:4.23%
cases:4.46%
controls:1.70%
—
—
—
—
—
—
cases:6.48%
controls:2.70%
cases:27.78%
controls:8.02%
6
47
105
1063
5
19
107
1096
—
—
—
7
29
101
1046
25
71
65
814
Shortness of breath/dyspnoea
R02 [2002000883]
—
—
—
—
—
—
1.5e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:13.33%
controls:3.39%
—
—
—
—
—
—
12
30
78
855
Holo-transcobalamin II [Moles/volume] in Serum
72160-5 [43054903]
2.7e-01
5.8e-01
—
—
—
—
1.4e+00
cases:7.21%
controls:5.59%
cases:6.25%
controls:3.59%
—
—
—
—
—
—
—
—
cases:37.78%
controls:12.54%
8
62
103
1048
7
40
105
1075
—
—
—
—
34
111
56
774
clindamycin; oral, parenteral
J01FF01 [21602985]
7.9e-01
—
—
—
—
—
1.4e+00
cases:6.31%
controls:2.97%
—
—
—
—
—
—
—
—
—
—
cases:13.33%
controls:3.50%
7
33
104
1077
—
—
—
—
—
12
31
78
854
Bacteria identified in Isolate by Culture
43409-2 [3042936]
—
—
—
—
—
—
1.4e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:13.33%
controls:3.62%
—
—
—
—
—
—
12
32
78
853
Spinalanesthesia
WX320 [2001310799]
1.4e+00
-1.0e+50
—
—
—
1.1e+00
—
cases:12.61%
controls:3.51%
cases:0.00%
controls:1.35%
—
—
—
—
—
—
cases:4.63%
controls:1.58%
—
—
14
39
97
1071
0
15
112
1100
—
—
—
5
17
103
1058
—
Clinical & Laboratory Dermatological Immunology Physician
207NI0002X [38003841]
8.4e-01
6.5e-01
—
1.0e+50
—
1.4e+00
8.9e-01
cases:14.41%
controls:6.76%
cases:5.36%
controls:2.87%
—
—
cases:9.82%
controls:0.00%
—
—
cases:12.04%
controls:3.35%
cases:16.67%
controls:7.57%
16
75
95
1035
6
32
106
1083
—
11
0
101
1115
—
13
36
95
1039
15
67
75
818
Right side
ZXA00 [2001311346]
3.0e-01
—
—
—
—
—
1.3e+00
cases:5.41%
controls:4.05%
—
—
—
—
—
—
—
—
—
—
cases:15.56%
controls:4.75%
6
45
105
1065
—
—
—
—
—
14
42
76
843
Albumin [Mass/volume] in Serum or Plasma
1751-7 [3024561]
1.0e-01
8.0e-01
—
—
-1.0e+50
7.3e-01
1.3e+00
cases:8.11%
controls:7.39%
cases:8.04%
controls:3.77%
—
—
—
—
cases:0.00%
controls:0.72%
cases:7.41%
controls:3.72%
cases:35.56%
controls:12.99%
9
82
102
1028
9
42
103
1073
—
—
0
8
112
1105
8
40
100
1035
32
115
58
770
Pain in limb
M79.6 [45587063]
1.4e-01
4.9e-01
—
—
—
—
1.3e+00
cases:8.11%
controls:7.12%
cases:4.46%
controls:2.78%
—
—
—
—
—
—
—
—
cases:22.22%
controls:7.34%
9
79
102
1031
5
31
107
1084
—
—
—
—
20
65
70
820
Monocytes/Leukocytes in Blood
26485-3 [3019069]
4.1e-01
5.2e-01
—
—
—
6.2e-01
1.3e+00
cases:11.71%
controls:8.11%
cases:8.04%
controls:4.93%
—
—
—
—
—
—
cases:8.33%
controls:4.65%
cases:34.44%
controls:12.77%
13
90
98
1020
9
55
103
1060
—
—
—
9
50
99
1025
31
113
59
772
Other specified counselling
Z71.8 [45581061]
—
—
—
—
-1.0e+50
—
1.3e+00
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.72%
—
—
cases:18.89%
controls:6.10%
—
—
—
—
0
8
112
1105
—
17
54
73
831
Nursing episode
950 [44777714]
1.1e+00
—
-1.0e+50
—
—
—
1.3e+00
cases:5.41%
controls:1.89%
—
—
cases:0.00%
controls:0.54%
—
—
—
—
—
—
cases:14.44%
controls:4.52%
6
21
105
1089
—
0
6
112
1109
—
—
—
13
40
77
845
Eosinophils/Leukocytes in Blood
26450-7 [3006504]
4.3e-01
5.0e-01
—
—
—
6.2e-01
1.3e+00
cases:11.71%
controls:7.93%
cases:8.04%
controls:5.02%
—
—
—
—
—
—
cases:8.33%
controls:4.65%
cases:34.44%
controls:12.88%
13
88
98
1022
9
56
103
1059
—
—
—
9
50
99
1025
31
114
59
771
aPTT in Platelet poor plasma by Coagulation assay
14979-9 [3018677]
1.2e+00
—
—
—
—
—
1.3e+00
cases:6.31%
controls:1.89%
—
—
—
—
—
—
—
—
—
—
cases:13.33%
controls:4.18%
7
21
104
1089
—
—
—
—
—
12
37
78
848
Bacteria identified in Blood by Culture
600-7 [3023368]
—
—
-1.0e+50
—
—
—
1.3e+00
—
—
—
—
cases:0.00%
controls:0.45%
—
—
—
—
—
—
cases:25.56%
controls:8.93%
—
—
0
5
112
1110
—
—
—
23
79
67
806
Pain in joint
M25.5 [45586941]
5.6e-01
-1.0e+50
—
—
—
9.4e-01
1.2e+00
cases:6.31%
controls:3.69%
cases:0.00%
controls:1.43%
—
—
—
—
—
—
cases:4.63%
controls:1.86%
cases:16.67%
controls:5.42%
7
41
104
1069
0
16
112
1099
—
—
—
5
20
103
1055
15
48
75
837
Bacteria [Presence] in Urine
87829-8 [36304419]
6.8e-01
1.1e+00
—
—
—
—
1.2e+00
cases:7.21%
controls:3.78%
cases:4.46%
controls:1.52%
—
—
—
—
—
—
—
—
cases:23.33%
controls:8.14%
8
42
103
1068
5
17
107
1098
—
—
—
—
21
72
69
813
Lymphocytes/Leukocytes in Blood
26478-8 [3002030]
2.6e-01
6.2e-01
—
—
—
8.0e-01
1.2e+00
cases:10.81%
controls:8.56%
cases:8.93%
controls:5.02%
—
—
—
—
—
—
cases:10.19%
controls:4.84%
cases:34.44%
controls:13.33%
12
95
99
1015
10
56
102
1059
—
—
—
11
52
97
1023
31
118
59
767
tramadol; oral, parenteral, rectal
N02AX02 [21604298]
1.2e+00
6.1e-01
—
—
-1.0e+50
7.8e-01
8.9e-01
cases:19.82%
controls:6.76%
cases:6.25%
controls:3.50%
—
—
—
—
cases:0.00%
controls:0.45%
cases:6.48%
controls:3.07%
cases:16.67%
controls:7.57%
22
75
89
1035
7
39
105
1076
—
—
0
5
112
1108
7
33
101
1042
15
67
75
818
Casts [#/volume] in Urine by Automated count
51483-6 [3030467]
4.9e-01
—
—
—
—
—
1.2e+00
cases:6.31%
controls:3.96%
—
—
—
—
—
—
—
—
—
—
cases:24.44%
controls:8.70%
7
44
104
1066
—
—
—
—
—
22
77
68
808
Basophils/Leukocytes in Blood
30180-4 [3022096]
4.4e-01
5.0e-01
—
—
—
6.2e-01
1.2e+00
cases:11.71%
controls:7.84%
cases:8.04%
controls:5.02%
—
—
—
—
—
—
cases:8.33%
controls:4.65%
cases:33.33%
controls:12.99%
13
87
98
1023
9
56
103
1059
—
—
—
9
50
99
1025
30
115
60
770
Normoblasts [#/volume] in Blood
715-3 [3021589]
1.5e-01
1.8e-01
—
—
1.5e+00
3.6e-01
1.2e+00
cases:9.01%
controls:7.84%
cases:8.04%
controls:6.82%
—
—
—
—
cases:4.46%
controls:1.08%
cases:8.33%
controls:5.95%
cases:32.22%
controls:12.54%
10
87
101
1023
9
76
103
1039
—
—
5
12
107
1101
9
64
99
1011
29
111
61
774
Neutrophils/Leukocytes in Blood
26511-6 [3018010]
2.7e-01
7.4e-01
—
—
—
8.0e-01
1.2e+00
cases:10.81%
controls:8.47%
cases:9.82%
controls:4.93%
—
—
—
—
—
—
cases:10.19%
controls:4.84%
cases:33.33%
controls:13.11%
12
94
99
1016
11
55
101
1060
—
—
—
11
52
97
1023
30
116
60
769
Cough
R05 [2002000886]
—
—
—
—
—
—
1.2e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:14.44%
controls:4.86%
—
—
—
—
—
—
13
43
77
842
Laboratory test
15220000 [4034850]
1.1e+00
—
—
—
—
—
1.1e+00
cases:5.41%
controls:1.89%
—
—
—
—
—
—
—
—
—
—
cases:15.56%
controls:5.54%
6
21
105
1089
—
—
—
—
—
14
49
76
836
pH of Serum or Plasma
2753-2 [3018418]
6.0e-01
1.6e+00
—
—
—
6.7e-01
1.1e+00
cases:8.11%
controls:4.59%
cases:6.25%
controls:1.35%
—
—
—
—
—
—
cases:4.63%
controls:2.42%
cases:22.22%
controls:8.36%
9
51
102
1059
7
15
105
1100
—
—
—
5
26
103
1049
20
74
70
811
Creatinine [Moles/volume] in Urine
14683-7 [3009508]
1.8e-01
8.5e-01
—
—
—
9.9e-01
1.1e+00
cases:6.31%
controls:5.32%
cases:6.25%
controls:2.78%
—
—
—
—
—
—
cases:8.33%
controls:3.26%
cases:28.89%
controls:11.64%
7
59
104
1051
7
31
105
1084
—
—
—
9
35
99
1040
26
103
64
782
Eosinophils [#/volume] in Blood
26449-9 [3013115]
5.5e-01
7.6e-01
—
—
—
7.7e-01
1.1e+00
cases:14.41%
controls:8.83%
cases:10.71%
controls:5.29%
—
—
—
—
—
—
cases:11.11%
controls:5.49%
cases:36.67%
controls:16.05%
16
98
95
1012
12
59
100
1056
—
—
—
12
59
96
1016
33
142
57
743
Neutrophils [#/volume] in Blood by Automated count
751-8 [3013650]
4.5e-01
6.1e-01
—
—
—
5.8e-01
1.1e+00
cases:16.22%
controls:10.99%
cases:10.71%
controls:6.10%
—
—
—
—
—
—
cases:11.11%
controls:6.51%
cases:38.89%
controls:17.51%
18
122
93
988
12
68
100
1047
—
—
—
12
70
96
1005
35
155
55
730
Hemoglobin A1c/Hemoglobin.total in Blood
4548-4 [3004410]
5.8e-02
3.4e-01
—
—
—
1.5e-01
1.1e+00
cases:22.52%
controls:21.53%
cases:19.64%
controls:14.80%
—
—
—
—
—
—
cases:17.59%
controls:15.53%
cases:67.78%
controls:41.58%
25
239
86
871
22
165
90
950
—
—
—
19
167
89
908
61
368
29
517
Type 2 diabetes mellitus, without complications
E11.9 [45561952]
8.4e-01
1.3e+00
—
1.0e+50
—
1.1e+00
1.1e+00
cases:10.81%
controls:4.95%
cases:8.93%
controls:2.69%
—
—
cases:5.36%
controls:0.00%
—
—
cases:8.33%
controls:2.98%
cases:20.00%
controls:7.91%
12
55
99
1055
10
30
102
1085
—
6
0
106
1115
—
9
32
99
1043
18
70
72
815
Monocytes [#/volume] in Blood
26484-6 [3001604]
4.6e-01
6.7e-01
—
—
—
8.0e-01
1.0e+00
cases:12.61%
controls:8.38%
cases:9.82%
controls:5.29%
—
—
—
—
—
—
cases:11.11%
controls:5.30%
cases:34.44%
controls:15.59%
14
93
97
1017
11
59
101
1056
—
—
—
12
57
96
1018
31
138
59
747
Albumin [Mass/volume] in Urine
1754-1 [3012516]
2.6e-01
7.2e-01
—
—
—
7.8e-01
1.0e+00
cases:6.31%
controls:4.95%
cases:5.36%
controls:2.69%
—
—
—
—
—
—
cases:7.41%
controls:3.53%
cases:26.67%
controls:11.41%
7
55
104
1055
6
30
106
1085
—
—
—
8
38
100
1037
24
101
66
784
Calcium.ionized [Moles/volume] in Serum or Plasma
1995-0 [3021347]
5.2e-01
1.2e+00
—
—
—
2.5e-01
1.0e+00
cases:12.61%
controls:7.93%
cases:7.14%
controls:2.33%
—
—
—
—
—
—
cases:4.63%
controls:3.63%
cases:30.00%
controls:13.22%
14
88
97
1022
8
26
104
1089
—
—
—
5
39
103
1036
27
117
63
768
paracetamol; oral, parenteral, rectal
N02BE01 [21604344]
4.9e-01
4.5e-01
3.1e-01
—
-6.6e-03
3.6e-01
1.0e+00
cases:48.65%
controls:36.67%
cases:29.46%
controls:20.99%
cases:6.25%
controls:4.66%
—
—
cases:4.46%
controls:4.49%
cases:28.70%
controls:21.95%
cases:68.89%
controls:44.07%
54
407
57
703
33
234
79
881
7
52
105
1063
—
5
50
107
1063
31
236
77
839
62
390
28
495
Upper gastrointestinal surgery
106 [44777669]
1.0e+00
3.9e-01
—
—
—
—
6.9e-01
cases:18.02%
controls:7.30%
cases:5.36%
controls:3.68%
—
—
—
—
—
—
—
—
cases:21.11%
controls:11.86%
20
81
91
1029
6
41
106
1074
—
—
—
—
19
105
71
780
Erythrocytes [#/volume] in Urine
30391-7 [3002582]
5.6e-01
8.4e-01
—
—
—
—
1.0e+00
cases:8.11%
controls:4.77%
cases:4.46%
controls:1.97%
—
—
—
—
—
—
—
—
cases:25.56%
controls:11.07%
9
53
102
1057
5
22
107
1093
—
—
—
—
23
98
67
787
INR in Blood by Coagulation assay
34714-6 [3032080]
3.4e-01
4.5e-01
9.5e-01
—
—
1.0e+00
7.3e-01
cases:12.61%
controls:9.28%
cases:8.04%
controls:5.29%
cases:6.25%
controls:2.51%
—
—
—
—
cases:14.81%
controls:5.95%
cases:31.11%
controls:17.85%
14
103
97
1007
9
59
103
1056
7
28
105
1087
—
—
16
64
92
1011
28
158
62
727
Laboratory Visit
OMOP4822461 [32036]
8.3e-02
1.9e-01
4.0e-01
1.3e+00
1.0e+00
3.3e-01
6.7e-01
cases:36.04%
controls:34.14%
cases:38.39%
controls:33.99%
cases:16.96%
controls:12.02%
cases:4.46%
controls:1.26%
cases:23.21%
controls:9.97%
cases:44.44%
controls:36.47%
cases:81.11%
controls:68.81%
40
379
71
731
43
379
69
736
19
134
93
981
5
14
107
1101
26
111
86
1002
48
392
60
683
73
609
17
276
Laceration/cut
S18 [2002000983]
1.4e-01
2.0e-01
-1.0e+50
—
—
9.1e-01
9.9e-01
cases:7.21%
controls:6.31%
cases:4.46%
controls:3.68%
cases:0.00%
controls:0.54%
—
—
—
—
cases:8.33%
controls:3.53%
cases:27.78%
controls:12.54%
8
70
103
1040
5
41
107
1074
0
6
112
1109
—
—
9
38
99
1037
25
111
65
774
Lymphocytes [#/volume] in Blood
26474-7 [3019198]
3.8e-01
6.3e-01
—
—
—
8.2e-01
9.9e-01
cases:12.61%
controls:9.01%
cases:9.82%
controls:5.47%
—
—
—
—
—
—
cases:12.04%
controls:5.67%
cases:34.44%
controls:16.38%
14
100
97
1010
11
61
101
1054
—
—
—
13
61
95
1014
31
145
59
740
cefalexin; oral
J01DB01 [21602870]
9.8e-01
8.9e-01
2.0e+00
—
—
8.3e-01
3.3e-01
cases:49.55%
controls:26.94%
cases:17.86%
controls:8.16%
cases:4.46%
controls:0.63%
—
—
—
—
cases:20.37%
controls:10.05%
cases:35.56%
controls:28.36%
55
299
56
811
20
91
92
1024
5
7
107
1108
—
—
22
108
86
967
32
251
58
634
Basophils [#/volume] in Blood
26444-0 [3006315]
4.4e-01
6.5e-01
—
—
—
7.8e-01
9.7e-01
cases:12.61%
controls:8.47%
cases:9.82%
controls:5.38%
—
—
—
—
—
—
cases:11.11%
controls:5.40%
cases:33.33%
controls:15.93%
14
94
97
1016
11
60
101
1055
—
—
—
12
58
96
1017
30
141
60
744
prednisolone; oral, parenteral
H02AB06 [21602734]
5.5e-01
4.5e-01
—
—
—
4.9e-01
9.5e-01
cases:17.12%
controls:10.63%
cases:7.14%
controls:4.66%
—
—
—
—
—
—
cases:7.41%
controls:4.65%
cases:26.67%
controls:12.32%
19
118
92
992
8
52
104
1063
—
—
—
8
50
100
1025
24
109
66
776
furosemide; oral, parenteral
C03CA01 [21601518]
9.4e-01
9.6e-01
—
—
—
8.2e-01
9.4e-01
cases:13.51%
controls:5.77%
cases:10.71%
controls:4.39%
—
—
—
—
—
—
cases:12.96%
controls:6.14%
cases:23.33%
controls:10.62%
15
64
96
1046
12
49
100
1066
—
—
—
14
66
94
1009
21
94
69
791
12 lead EKG panel
34534-8 [3044889]
9.8e-02
2.3e-01
—
—
—
3.2e-01
9.3e-01
cases:14.41%
controls:13.24%
cases:9.82%
controls:7.98%
—
—
—
—
—
—
cases:12.04%
controls:9.02%
cases:48.89%
controls:27.34%
16
147
95
963
11
89
101
1026
—
—
—
13
97
95
978
44
242
46
643
Leukocytes [#/volume] in Urine
30405-5 [3018095]
2.9e-01
9.9e-01
—
—
—
—
9.3e-01
cases:7.21%
controls:5.50%
cases:5.36%
controls:2.06%
—
—
—
—
—
—
—
—
cases:25.56%
controls:11.98%
8
61
103
1049
6
23
106
1092
—
—
—
—
23
106
67
779
prednisolone
A07EA01 [21600653]
6.0e-01
4.5e-01
—
—
—
4.7e-01
9.0e-01
cases:18.02%
controls:10.72%
cases:7.14%
controls:4.66%
—
—
—
—
—
—
cases:7.41%
controls:4.74%
cases:26.67%
controls:12.88%
20
119
91
991
8
52
104
1063
—
—
—
8
51
100
1024
24
114
66
771
Bacteria [#/volume] in Urine by Automated count
51480-2 [3031040]
2.9e-01
6.3e-01
—
—
—
5.6e-01
8.8e-01
cases:15.32%
controls:11.89%
cases:9.82%
controls:5.47%
—
—
—
—
—
—
cases:12.04%
controls:7.26%
cases:43.33%
controls:24.07%
17
132
94
978
11
61
101
1054
—
—
—
13
78
95
997
39
213
51
672
Glucose [Moles/volume] in Serum or Plasma
14749-6 [3013826]
1.6e-01
3.6e-01
—
—
—
4.2e-02
8.7e-01
cases:11.71%
controls:10.18%
cases:7.14%
controls:5.11%
—
—
—
—
—
—
cases:6.48%
controls:6.23%
cases:37.78%
controls:20.23%
13
113
98
997
8
57
104
1058
—
—
—
7
67
101
1008
34
179
56
706
salbutamol; inhalant
R03AC02 [21603256]
7.3e-01
5.3e-01
—
—
—
3.4e-01
8.7e-01
cases:26.13%
controls:14.59%
cases:13.39%
controls:8.34%
—
—
—
—
—
—
cases:12.04%
controls:8.84%
cases:30.00%
controls:15.25%
29
162
82
948
15
93
97
1022
—
—
—
13
95
95
980
27
135
63
750
CBC panel - Blood by Automated count
58410-2 [40761511]
1.4e-01
2.4e-02
2.5e-01
—
8.9e-01
5.4e-01
8.6e-01
cases:27.93%
controls:25.14%
cases:18.75%
controls:18.39%
cases:4.46%
controls:3.50%
—
—
cases:7.14%
controls:3.05%
cases:29.63%
controls:19.63%
cases:73.33%
controls:53.67%
31
279
80
831
21
205
91
910
5
39
107
1076
—
8
34
104
1079
32
211
76
864
66
475
24
410
Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
19072-8 [3016431]
5.2e-01
8.3e-01
—
—
—
4.4e-01
8.4e-01
cases:13.51%
controls:8.47%
cases:7.14%
controls:3.23%
—
—
—
—
—
—
cases:6.48%
controls:4.28%
cases:31.11%
controls:16.27%
15
94
96
1016
8
36
104
1079
—
—
—
7
46
101
1029
28
144
62
741
General Practice
1 [38004446]
8.3e-01
-7.9e-02
—
—
-1.0e+50
-3.7e-01
3.7e-01
cases:25.23%
controls:12.79%
cases:6.25%
controls:6.73%
—
—
—
—
cases:0.00%
controls:0.99%
cases:5.56%
controls:7.81%
cases:25.56%
controls:19.21%
28
142
83
968
7
75
105
1040
—
—
0
11
112
1102
6
84
102
991
23
170
67
715
Cholesterol in LDL [Moles/volume] in Serum or Plasma
22748-8 [3001308]
8.6e-02
1.4e-01
—
—
—
1.7e-01
8.0e-01
cases:26.13%
controls:24.50%
cases:18.75%
controls:16.68%
—
—
—
—
—
—
cases:19.44%
controls:16.93%
cases:67.78%
controls:48.59%
29
272
82
838
21
186
91
929
—
—
—
21
182
87
893
61
430
29
455
Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M
62238-1 [40764999]
-2.4e-01
-6.4e-02
3.1e-01
—
1.1e+00
-5.2e-02
7.6e-01
cases:17.12%
controls:20.72%
cases:16.07%
controls:16.95%
cases:4.46%
controls:3.32%
—
—
cases:8.93%
controls:3.14%
cases:16.67%
controls:17.40%
cases:55.56%
controls:36.95%
19
230
92
880
18
189
94
926
5
37
107
1078
—
10
35
102
1078
18
187
90
888
50
327
40
558
Health maint/preventive medicine
A98 [2002000231]
2.0e-01
7.5e-01
-2.5e-02
—
6.2e-01
5.4e-01
7.9e-01
cases:38.74%
controls:34.14%
cases:45.54%
controls:28.34%
cases:4.46%
controls:4.57%
—
—
cases:8.04%
controls:4.49%
cases:39.81%
controls:27.81%
cases:76.67%
controls:59.77%
43
379
68
731
51
316
61
799
5
51
107
1064
—
9
50
103
1063
43
299
65
776
69
529
21
356
pH of Specimen
17433-4 [3019225]
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.56%
—
—
—
—
—
—
—
0
6
108
1069
—
Cystitis/urinary infection other
U71 [2002001191]
—
-1.0e+50
—
—
—
—
—
—
—
cases:0.00%
controls:0.72%
—
—
—
—
—
—
—
—
—
—
—
0
8
112
1107
—
—
—
—
—
Gynecological ultrasound examination as part of clinical examination
LX1AE [2001306815]
-1.0e+50
—
—
—
—
—
-1.0e+50
cases:0.00%
controls:1.17%
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:1.13%
0
13
111
1097
—
—
—
—
—
0
10
90
875
Other spondylosis with radiculopathy
M47.2 [45591850]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.63%
—
—
—
—
—
—
—
—
—
—
—
—
0
7
111
1103
—
—
—
—
—
—
Monitored bed care
WX892 [2001310850]
—
—
—
—
—
—
2.1e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:5.56%
controls:0.68%
—
—
—
—
—
—
5
6
85
879
isosorbide dinitrate; local oral, oral, sublingual, transdermal
C01DA08 [21600321]
-6.8e-02
—
-1.0e+50
—
-1.0e+50
—
4.9e-01
cases:5.41%
controls:5.77%
—
—
cases:0.00%
controls:0.81%
—
—
cases:0.00%
controls:0.81%
—
—
cases:13.33%
controls:8.59%
6
64
105
1046
—
0
9
112
1106
—
0
9
112
1104
—
12
76
78
809
fluconazole; oral, parenteral
J02AC01 [21603080]
—
—
-1.0e+50
—
—
—
4.9e-01
—
—
—
—
cases:0.00%
controls:0.45%
—
—
—
—
—
—
cases:6.67%
controls:4.18%
—
—
0
5
112
1110
—
—
—
6
37
84
848
General health counselling
SPAT1312 [2001700413]
-8.1e-02
—
-1.0e+50
—
—
—
—
cases:4.50%
controls:4.86%
—
—
cases:0.00%
controls:0.45%
—
—
—
—
—
—
—
—
5
54
106
1056
—
0
5
112
1110
—
—
—
—
MCH [Entitic mass]
28539-5 [3035941]
2.9e-02
8.1e-02
4.6e-01
—
8.8e-01
5.2e-01
6.9e-01
cases:31.53%
controls:30.90%
cases:29.46%
controls:27.80%
cases:8.93%
controls:5.83%
—
—
cases:12.50%
controls:5.57%
cases:40.74%
controls:28.93%
cases:77.78%
controls:63.73%
35
343
76
767
33
310
79
805
10
65
102
1050
—
14
62
98
1051
44
311
64
764
70
564
20
321
Allergic rhinitis due to pollen
J30.10 [2000502594]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.45%
—
—
—
—
—
—
—
—
—
—
—
—
0
5
111
1105
—
—
—
—
—
—
diazepam; oral, parenteral, rectal
N05BA01 [21604566]
7.2e-01
—
—
—
—
—
—
cases:5.41%
controls:2.70%
—
—
—
—
—
—
—
—
—
—
—
—
6
30
105
1080
—
—
—
—
—
—
Assessment of need for services (elderly/care support)
SPAT1217 [2001700318]
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.74%
—
—
—
—
—
—
—
0
8
108
1067
—
SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
94500-6 [706163]
4.4e-01
—
-1.0e+50
—
—
—
1.4e-01
cases:16.22%
controls:11.08%
—
—
cases:0.00%
controls:0.81%
—
—
—
—
—
—
cases:10.00%
controls:8.81%
18
123
93
987
—
0
9
112
1106
—
—
—
9
78
81
807
Cutaneous abscess, furuncle and carbuncle of buttock
L02.3 [45548181]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.68%
—
—
—
—
—
—
0
6
90
879
Percutaneous puncture of bladder
TKC10 [2001306019]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.56%
—
—
—
—
—
—
0
5
90
880
Handing over of treatment supplies
SPAT1262 [2001700363]
—
-1.0e+50
-1.0e+50
—
—
-1.0e+50
—
—
—
cases:0.00%
controls:2.78%
cases:0.00%
controls:0.54%
—
—
—
—
cases:0.00%
controls:2.42%
—
—
—
0
31
112
1084
0
6
112
1109
—
—
0
26
108
1049
—
Nitrite [Presence] in Urine by Test strip
5802-4 [3021601]
4.8e-01
5.6e-01
—
—
—
1.5e-01
-8.1e-01
cases:12.61%
controls:8.20%
cases:8.04%
controls:4.75%
—
—
—
—
—
—
cases:5.56%
controls:4.84%
cases:8.89%
controls:17.97%
14
91
97
1019
9
53
103
1062
—
—
—
6
52
102
1023
8
159
82
726
insulin degludec; parenteral
A10AE06 [43534747]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.56%
—
—
—
—
—
—
0
5
90
880
Erythrocytes [#/volume] in Blood
26453-1 [3026361]
2.5e-02
8.1e-02
4.3e-01
—
8.7e-01
5.2e-01
6.9e-01
cases:31.53%
controls:30.99%
cases:29.46%
controls:27.80%
cases:8.93%
controls:6.01%
—
—
cases:12.50%
controls:5.66%
cases:40.74%
controls:29.12%
cases:77.78%
controls:63.73%
35
344
76
766
33
310
79
805
10
67
102
1048
—
14
63
98
1050
44
313
64
762
70
564
20
321
acetylsalicylic acid, combinations excl. psycholeptics
N02BA51 [21604320]
—
-1.0e+50
-1.0e+50
—
-1.0e+50
-1.0e+50
—
—
—
cases:0.00%
controls:1.70%
cases:0.00%
controls:0.72%
—
—
cases:0.00%
controls:0.45%
cases:0.00%
controls:1.77%
—
—
—
0
19
112
1096
0
8
112
1107
—
0
5
112
1108
0
19
108
1056
—
Oral Surgery
19 [38004464]
-1.0e+50
-1.0e+50
—
—
—
—
—
cases:0.00%
controls:0.81%
cases:0.00%
controls:0.54%
—
—
—
—
—
—
—
—
—
—
0
9
111
1101
0
6
112
1109
—
—
—
—
—
Erythrocytes [Presence] in Urine
33051-4 [3045424]
—
-1.0e+50
—
—
—
—
—
—
—
cases:0.00%
controls:0.63%
—
—
—
—
—
—
—
—
—
—
—
0
7
112
1108
—
—
—
—
—
hydrocortisone
D07XA01 [21602180]
8.0e-01
-1.0e+50
—
—
—
-1.0e+50
—
cases:4.50%
controls:2.07%
cases:0.00%
controls:0.90%
—
—
—
—
—
—
cases:0.00%
controls:0.74%
—
—
5
23
106
1087
0
10
112
1105
—
—
—
0
8
108
1067
—
Unspecified dementia
F03 [45566772]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.54%
—
—
—
—
—
—
—
—
—
—
—
—
0
6
111
1104
—
—
—
—
—
—
Balloon angioplasty and metallic stent
AN3 [2000200165]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.54%
—
—
—
—
—
—
—
—
—
—
—
—
0
6
111
1104
—
—
—
—
—
—
Sedation and analgesia
WX002 [2001310758]
6.5e-01
—
—
—
—
—
1.2e+00
cases:5.41%
controls:2.88%
—
—
—
—
—
—
—
—
—
—
cases:12.22%
controls:4.07%
6
32
105
1078
—
—
—
—
—
11
36
79
849
Overall medication plan or its review
SPAT1252 [2001700353]
-1.0e+50
—
—
—
—
-1.0e+50
-1.0e+50
cases:0.00%
controls:0.63%
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.56%
cases:0.00%
controls:1.02%
0
7
111
1103
—
—
—
—
0
6
108
1069
0
9
90
876
Cardiovascular sympt/complt other
K29 [2002000556]
-1.0e+50
—
—
—
—
—
-1.0e+50
cases:0.00%
controls:0.54%
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.79%
0
6
111
1104
—
—
—
—
—
0
7
90
878
Tooth plaque
K03.66 [2000502691]
-1.0e+50
-1.0e+50
—
—
—
—
—
cases:0.00%
controls:0.90%
cases:0.00%
controls:0.45%
—
—
—
—
—
—
—
—
—
—
0
10
111
1100
0
5
112
1110
—
—
—
—
—
Conjunctival surface anesthesia
WX100 [2001310764]
1.7e+00
—
—
—
—
—
1.4e+00
cases:4.50%
controls:0.81%
—
—
—
—
—
—
—
—
—
—
cases:6.67%
controls:1.81%
5
9
106
1101
—
—
—
—
—
6
16
84
869
metronidazole; vaginal
G01AF01 [21602392]
—
-1.0e+50
—
—
—
-1.0e+50
—
—
—
cases:0.00%
controls:0.81%
—
—
—
—
—
—
cases:0.00%
controls:0.93%
—
—
—
0
9
112
1106
—
—
—
0
10
108
1065
—
Removal of sutures
SPAT1153 [2001700254]
—
-1.0e+50
—
—
—
—
—
—
—
cases:0.00%
controls:2.69%
—
—
—
—
—
—
—
—
—
—
—
0
30
112
1085
—
—
—
—
—
Cholesterol [Moles/volume] in Serum or Plasma
14647-2 [3019900]
1.7e-01
8.3e-02
—
—
—
1.6e-01
2.9e-01
cases:26.13%
controls:23.06%
cases:16.07%
controls:14.98%
—
—
—
—
—
—
cases:16.67%
controls:14.60%
cases:53.33%
controls:46.10%
29
256
82
854
18
167
94
948
—
—
—
18
157
90
918
48
408
42
477
Biopsy of endometrium
LCA06 [2001306551]
-1.0e+50
-1.0e+50
—
—
—
—
-1.0e+50
cases:0.00%
controls:1.17%
cases:0.00%
controls:0.45%
—
—
—
—
—
—
—
—
cases:0.00%
controls:1.13%
0
13
111
1097
0
5
112
1110
—
—
—
—
0
10
90
875
Opening and preparing the root canals, extremely complicated
SGA04 [2001310382]
—
—
—
—
—
—
1.2e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:5.56%
controls:1.81%
—
—
—
—
—
—
5
16
85
869
Vaccination
SPAT1325 [2001700426]
—
—
—
—
-1.0e+50
-1.0e+50
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.45%
cases:0.00%
controls:4.74%
—
—
—
—
—
—
0
5
112
1108
0
51
108
1024
—
Osmolality of Urine
2695-5 [3026782]
—
1.3e+00
—
—
—
—
6.7e-01
—
—
cases:4.46%
controls:1.26%
—
—
—
—
—
—
—
—
cases:15.56%
controls:8.59%
—
5
14
107
1101
—
—
—
—
14
76
76
809
Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
7970-7 [3018387]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.45%
—
—
—
—
—
—
—
—
—
—
—
—
0
5
111
1105
—
—
—
—
—
—
Observ/health educat/advice/diet
-45 [2002000116]
-1.0e+50
-1.0e+50
—
—
—
—
—
cases:0.00%
controls:0.45%
cases:0.00%
controls:0.45%
—
—
—
—
—
—
—
—
—
—
0
5
111
1105
0
5
112
1110
—
—
—
—
—
Skin injury other
S19 [2002000984]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.45%
—
—
—
—
—
—
—
—
—
—
—
—
0
5
111
1105
—
—
—
—
—
—
Bacteria identified in Stool by Culture
625-4 [3025941]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.63%
—
—
—
—
—
—
—
—
—
—
—
—
0
7
111
1103
—
—
—
—
—
—
misoprostol; oral, vaginal
G02AD06 [21602443]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.54%
—
—
—
—
—
—
—
—
—
—
—
—
0
6
111
1104
—
—
—
—
—
—
Polyarthrosis, unspecified
M15.9 [45543481]
-1.0e+50
-1.0e+50
—
—
—
-1.0e+50
—
cases:0.00%
controls:0.72%
cases:0.00%
controls:0.72%
—
—
—
—
—
—
cases:0.00%
controls:0.47%
—
—
0
8
111
1102
0
8
112
1107
—
—
—
0
5
108
1070
—
Cramp and spasm
R25.2 [45592414]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.45%
—
—
—
—
—
—
—
—
—
—
—
—
0
5
111
1105
—
—
—
—
—
—
Puncture of pleura with ultrasound guidance
GA4YT [2001303531]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.56%
—
—
—
—
—
—
0
5
90
880
salmeterol and fluticasone
R03AK06 [21603280]
1.6e-01
—
—
—
—
—
1.3e+00
cases:4.50%
controls:3.87%
—
—
—
—
—
—
—
—
—
—
cases:11.11%
controls:3.39%
5
43
106
1067
—
—
—
—
—
10
30
80
855
CBC W Ordered Manual Differential panel - Blood
57782-5 [40760892]
2.1e-01
6.7e-01
—
—
—
1.1e+00
—
cases:4.50%
controls:3.69%
cases:4.46%
controls:2.33%
—
—
—
—
—
—
cases:4.63%
controls:1.58%
—
—
5
41
106
1069
5
26
107
1089
—
—
—
5
17
103
1058
—
chloramphenicol
G01AA05 [21602367]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.90%
—
—
—
—
—
—
0
8
90
877
fluticasone, combinations
R01AD58 [43534837]
6.7e-01
—
—
—
—
—
3.1e-01
cases:6.31%
controls:3.33%
—
—
—
—
—
—
—
—
—
—
cases:6.67%
controls:4.97%
7
37
104
1073
—
—
—
—
—
6
44
84
841
pH of Blood
11558-4 [3010421]
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.56%
—
—
—
—
—
—
—
0
6
108
1069
—
Paroxysmal atrial fibrillation
I48.0 [45581776]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.68%
—
—
—
—
—
—
0
6
90
879
Rhinopharyngoscopy
UDH02 [2001301680]
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.47%
—
—
—
—
—
—
—
0
5
108
1070
—
lidocaine; ointment
D04AB01 [21602020]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:1.24%
—
—
—
—
—
—
0
11
90
874
orphenadrine (citrate); oral, parenteral
M03BC01 [21604112]
6.5e-01
—
—
—
—
—
8.0e-01
cases:10.81%
controls:5.95%
—
—
—
—
—
—
—
—
—
—
cases:12.22%
controls:5.88%
12
66
99
1044
—
—
—
—
—
11
52
79
833
levodopa and decarboxylase inhibitor; oral
N04BA02 [21604465]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.72%
—
—
—
—
—
—
—
—
—
—
—
—
0
8
111
1102
—
—
—
—
—
—
Polyarthrosis
M15 [45596490]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.81%
—
—
—
—
—
—
—
—
—
—
—
—
0
9
111
1101
—
—
—
—
—
—
clobetasol
D07AD01 [21602141]
-1.0e+50
-1.0e+50
—
—
—
—
—
cases:0.00%
controls:2.52%
cases:0.00%
controls:0.90%
—
—
—
—
—
—
—
—
—
—
0
28
111
1082
0
10
112
1105
—
—
—
—
—
Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
10886-0 [3005013]
4.8e-01
—
—
—
—
—
6.0e-01
cases:5.41%
controls:3.42%
—
—
—
—
—
—
—
—
—
—
cases:12.22%
controls:7.12%
6
38
105
1072
—
—
—
—
—
11
63
79
822
Restricted oral and dental health check by dental hygienist or dental assistant
SAB01 [2001310279]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:1.69%
—
—
—
—
—
—
0
15
90
870
Urate [Moles/volume] in Serum or Plasma
14933-6 [3026493]
2.7e-01
—
—
—
—
1.6e+00
9.8e-01
cases:6.31%
controls:4.86%
—
—
—
—
—
—
—
—
cases:7.41%
controls:1.58%
cases:18.89%
controls:8.02%
7
54
104
1056
—
—
—
—
8
17
100
1058
17
71
73
814
Lumbar spine MRI examination with high intensity magnet
NA3BG [2001307034]
—
—
—
—
—
—
1.7e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:7.78%
controls:1.58%
—
—
—
—
—
—
7
14
83
871
Calcium [Moles/volume] in Serum or Plasma
2000-8 [3015377]
—
4.0e-01
—
—
-1.0e+50
5.6e-01
4.7e-01
—
—
cases:4.46%
controls:3.05%
—
—
—
—
cases:0.00%
controls:0.63%
cases:4.63%
controls:2.70%
cases:15.56%
controls:10.28%
—
5
34
107
1081
—
—
0
7
112
1106
5
29
103
1046
14
91
76
794
Palpitations
R00.2 [45558446]
-1.0e+50
—
—
—
—
—
-1.0e+50
cases:0.00%
controls:0.54%
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.68%
0
6
111
1104
—
—
—
—
—
0
6
90
879
Adjustment and management of cardiac devices
Z45.0 [45595515]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.45%
—
—
—
—
—
—
—
—
—
—
—
—
0
5
111
1105
—
—
—
—
—
—
Limited function/disability NOS
A28 [2002000162]
—
—
—
—
—
—
5.1e-01
—
—
—
—
—
—
—
—
—
—
—
—
cases:8.89%
controls:5.54%
—
—
—
—
—
—
8
49
82
836
tiotropium bromide; inhalant
R03BB04 [21603296]
3.4e-01
8.8e-01
—
—
—
7.8e-01
6.6e-01
cases:4.50%
controls:3.24%
cases:6.25%
controls:2.69%
—
—
—
—
—
—
cases:6.48%
controls:3.07%
cases:5.56%
controls:2.94%
5
36
106
1074
7
30
105
1085
—
—
—
7
33
101
1042
5
26
85
859
Risk factor NOS
A23 [2002000158]
—
-1.0e+50
—
—
—
—
—
—
—
cases:0.00%
controls:0.63%
—
—
—
—
—
—
—
—
—
—
—
0
7
112
1108
—
—
—
—
—
Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
48065-7 [3051714]
—
—
—
—
—
—
9.7e-01
—
—
—
—
—
—
—
—
—
—
—
—
cases:13.33%
controls:5.54%
—
—
—
—
—
—
12
49
78
836
Severe depressive episode without psychotic symptoms
F32.2 [45557202]
-1.0e+50
—
—
—
—
—
-1.0e+50
cases:0.00%
controls:0.72%
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:1.02%
0
8
111
1102
—
—
—
—
—
0
9
90
876
Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
5253-0 [3027545]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.99%
—
—
—
—
—
—
—
—
—
—
—
—
0
11
111
1099
—
—
—
—
—
—
Speech audiometry
252592009 [4091138]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.79%
—
—
—
—
—
—
0
7
90
878
Cone beam imaging of teeth and jaws (1–2 quarters)
EB1BI [2001301908]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.45%
—
—
—
—
—
—
—
—
—
—
—
—
0
5
111
1105
—
—
—
—
—
—
Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
25373-2 [3019145]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.68%
—
—
—
—
—
—
0
6
90
879
Cocaine [Presence] in Urine
3397-7 [3016879]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.63%
—
—
—
—
—
—
—
—
—
—
—
—
0
7
111
1103
—
—
—
—
—
—
venlafaxine; oral
N06AX16 [21604745]
1.2e+00
—
—
—
—
—
—
cases:5.41%
controls:1.71%
—
—
—
—
—
—
—
—
—
—
—
—
6
19
105
1091
—
—
—
—
—
—
estradiol; nasal, oral, parenteral, rectal, transdermal, vaginal
G03CA03 [21602517]
2.2e-02
3.9e-01
—
—
—
6.8e-01
3.4e-01
cases:14.41%
controls:14.14%
cases:12.50%
controls:8.79%
—
—
—
—
—
—
cases:15.74%
controls:8.65%
cases:17.78%
controls:13.33%
16
157
95
953
14
98
98
1017
—
—
—
17
93
91
982
16
118
74
767
Myalgia
M79.1 [45587062]
—
-1.0e+50
—
—
—
—
—
—
—
cases:0.00%
controls:0.72%
—
—
—
—
—
—
—
—
—
—
—
0
8
112
1107
—
—
—
—
—
Dementia
P70 [2002000864]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.79%
—
—
—
—
—
—
0
7
90
878
fluticasone furoate; nasal
R01AD12 [21605053]
3.3e-02
3.8e-02
—
—
-1.0e+50
—
-2.6e-01
cases:9.01%
controls:8.74%
cases:4.46%
controls:4.30%
—
—
—
—
cases:0.00%
controls:1.17%
—
—
cases:7.78%
controls:9.83%
10
97
101
1013
5
48
107
1067
—
—
0
13
112
1100
—
7
87
83
798
budesonide; inhalant
R03BA02 [21603285]
1.7e-01
6.7e-01
—
—
—
1.8e-01
7.6e-01
cases:7.21%
controls:6.13%
cases:7.14%
controls:3.77%
—
—
—
—
—
—
cases:4.63%
controls:3.91%
cases:12.22%
controls:6.10%
8
68
103
1042
8
42
104
1073
—
—
—
5
42
103
1033
11
54
79
831
hydrocortisone buteprate
D07AB11 [21602115]
5.4e-01
8.5e-01
-1.0e+50
—
-1.0e+50
4.9e-01
3.2e-01
cases:12.61%
controls:7.75%
cases:6.25%
controls:2.78%
cases:0.00%
controls:0.90%
—
—
cases:0.00%
controls:0.45%
cases:4.63%
controls:2.88%
cases:10.00%
controls:7.46%
14
86
97
1024
7
31
105
1084
0
10
112
1105
—
0
5
112
1108
5
31
103
1044
9
66
81
819
Acute vaginitis
N76.0 [45543891]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.56%
—
—
—
—
—
—
0
5
90
880
formoterol; inhalant
R03AC13 [21603267]
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.47%
—
—
—
—
—
—
—
0
5
108
1070
—
dexamethasone
S02BA06 [21605168]
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.56%
—
—
—
—
—
—
—
0
6
108
1069
—
Carpal tunnel syndrome
G56.0 [45566891]
—
-1.0e+50
—
—
—
—
—
—
—
cases:0.00%
controls:0.72%
—
—
—
—
—
—
—
—
—
—
—
0
8
112
1107
—
—
—
—
—
Corticotropin [Mass/volume] in Plasma
2141-0 [3035637]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.45%
—
—
—
—
—
—
—
—
—
—
—
—
0
5
111
1105
—
—
—
—
—
—
Leiomyoma of uterus, unspecified
D25.9 [45542693]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.63%
—
—
—
—
—
—
—
—
—
—
—
—
0
7
111
1103
—
—
—
—
—
—
Capsular glaucoma with pseudoexfoliation on the anterior lens capsule
H40.10 [2000502332]
-1.0e+50
-1.0e+50
—
—
—
-1.0e+50
-1.0e+50
cases:0.00%
controls:0.63%
cases:0.00%
controls:0.90%
—
—
—
—
—
—
cases:0.00%
controls:0.65%
cases:0.00%
controls:1.24%
0
7
111
1103
0
10
112
1105
—
—
—
0
7
108
1068
0
11
90
874
Supine thorax X-ray examination
GD1QA [2001303648]
1.4e+00
—
—
—
—
—
5.5e-01
cases:6.31%
controls:1.62%
—
—
—
—
—
—
—
—
—
—
cases:6.67%
controls:3.95%
7
18
104
1092
—
—
—
—
—
6
35
84
850
Emergency procedure
ZXD00 [2001311385]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.81%
—
—
—
—
—
—
—
—
—
—
—
—
0
9
111
1101
—
—
—
—
—
—
Sepsis due to other Gram-negative organisms
A41.5 [45556902]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.68%
—
—
—
—
—
—
0
6
90
879
Fever
A03 [2002000144]
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.93%
—
—
—
—
—
—
—
0
10
108
1065
—
Fall on same level from slipping, tripping and stumbling
W01 [45756243]
1.1e+00
—
-1.0e+50
—
—
8.4e-01
3.9e-01
cases:10.81%
controls:3.96%
—
—
cases:0.00%
controls:0.45%
—
—
—
—
cases:4.63%
controls:2.05%
cases:8.89%
controls:6.21%
12
44
99
1066
—
0
5
112
1110
—
—
5
22
103
1053
8
55
82
830
zopiclone; oral
N05CF01 [21604654]
6.1e-01
-4.8e-03
—
—
—
-2.0e-02
4.1e-01
cases:15.32%
controls:8.92%
cases:6.25%
controls:6.28%
—
—
—
—
—
—
cases:6.48%
controls:6.60%
cases:14.44%
controls:10.06%
17
99
94
1011
7
70
105
1045
—
—
—
7
71
101
1004
13
89
77
796
Type 2 diabetes mellitus, with unspecified complications
E11.8 [45561951]
—
—
—
—
—
—
4.8e-01
—
—
—
—
—
—
—
—
—
—
—
—
cases:5.56%
controls:3.50%
—
—
—
—
—
—
5
31
85
854
Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
72720-6 [43055554]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.54%
—
—
—
—
—
—
—
—
—
—
—
—
0
6
111
1104
—
—
—
—
—
—
Acute maxillary sinusitis
J01.0 [45601112]
5.9e-01
—
-1.0e+50
—
—
—
1.2e+00
cases:5.41%
controls:3.06%
—
—
cases:0.00%
controls:0.45%
—
—
—
—
—
—
cases:10.00%
controls:3.28%
6
34
105
1076
—
0
5
112
1110
—
—
—
9
29
81
856
Trichilemmal cyst
L72.1 [45596386]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:1.02%
—
—
—
—
—
—
0
9
90
876
Bicarbonate [Moles/volume] in Serum or Plasma
1963-8 [3016293]
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.74%
—
—
—
—
—
—
—
0
8
108
1067
—
Multidisciplinary treatment meeting
WZC20 [2001310890]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.56%
—
—
—
—
—
—
0
5
90
880
olanzapine; oral, parenteral
N05AH03 [21604543]
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.45%
—
—
—
—
—
—
—
—
0
5
112
1108
—
—
terbutaline; inhalant
R03AC03 [21603257]
—
-1.0e+50
—
—
—
—
—
—
—
cases:0.00%
controls:1.08%
—
—
—
—
—
—
—
—
—
—
—
0
12
112
1103
—
—
—
—
—
Intramuscular and subcutaneous injection
SPAT1256 [2001700357]
—
—
-1.0e+50
—
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.54%
—
—
cases:0.00%
controls:0.90%
—
—
—
—
—
—
0
6
112
1109
—
0
10
112
1103
—
—
Interscalenous plexus blockade
WX200 [2001310777]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.45%
—
—
—
—
—
—
—
—
—
—
—
—
0
5
111
1105
—
—
—
—
—
—
Moderate depressive episode without somatic syndrome
F32.10 [2000501980]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:1.17%
—
—
—
—
—
—
—
—
—
—
—
—
0
13
111
1097
—
—
—
—
—
—
Sex hormone binding globulin [Moles/volume] in Serum or Plasma
13967-5 [3004248]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.90%
—
—
—
—
—
—
0
8
90
877
Pneumonia
R81 [2002000949]
-1.0e+50
—
—
—
—
—
-1.0e+50
cases:0.00%
controls:0.54%
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.68%
0
6
111
1104
—
—
—
—
—
0
6
90
879
Breast cancer
115 [2001600115]
-1.0e+50
—
—
—
—
—
-1.0e+50
cases:0.00%
controls:0.99%
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.56%
0
11
111
1099
—
—
—
—
—
0
5
90
880
Open wound of toe(s) without damage to nail
S91.1 [45545948]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.45%
—
—
—
—
—
—
—
—
—
—
—
—
0
5
111
1105
—
—
—
—
—
—
Borrelia burgdorferi IgM Ab [Units/volume] in Serum
7818-8 [3008230]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:1.24%
—
—
—
—
—
—
0
11
90
874
fluticasone; inhalant
R03BA05 [21603288]
3.7e-01
—
—
—
—
—
5.2e-01
cases:5.41%
controls:3.78%
—
—
—
—
—
—
—
—
—
—
cases:5.56%
controls:3.39%
6
42
105
1068
—
—
—
—
—
5
30
85
855
Extensive global examination
SPAT1360 [2001700461]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.81%
—
—
—
—
—
—
—
—
—
—
—
—
0
9
111
1101
—
—
—
—
—
—
Celiac disease serology panel - Serum
94494-2 [36660697]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.81%
—
—
—
—
—
—
—
—
—
—
—
—
0
9
111
1101
—
—
—
—
—
—
Alzheimer disease
G30 [45538101]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:1.08%
—
—
—
—
—
—
—
—
—
—
—
—
0
12
111
1098
—
—
—
—
—
—
C reactive protein [Mass/volume] in Serum or Plasma
1988-5 [3020460]
8.3e-02
4.2e-01
4.7e-01
—
9.5e-01
5.3e-01
6.8e-01
cases:25.23%
controls:23.69%
cases:23.21%
controls:16.59%
cases:5.36%
controls:3.41%
—
—
cases:7.14%
controls:2.88%
cases:27.78%
controls:18.42%
cases:63.33%
controls:46.55%
28
263
83
847
26
185
86
930
6
38
106
1077
—
8
32
104
1081
30
198
78
877
57
412
33
473
Hip symptom/complaint
L13 [2002000637]
-1.0e+50
-1.0e+50
—
—
—
-1.0e+50
6.1e-01
cases:0.00%
controls:2.07%
cases:0.00%
controls:0.72%
—
—
—
—
—
—
cases:0.00%
controls:0.84%
cases:6.67%
controls:3.73%
0
23
111
1087
0
8
112
1107
—
—
—
0
9
108
1066
6
33
84
852
Routine general health check-up of other defined subpopulations
Z10.8 [45609907]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.68%
—
—
—
—
—
—
0
6
90
879
Contraception intrauterine
W12 [2002001212]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:1.02%
—
—
—
—
—
—
0
9
90
876
Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
2157-6 [3007220]
5.4e-01
—
—
—
—
8.4e-01
6.1e-01
cases:8.11%
controls:4.86%
—
—
—
—
—
—
—
—
cases:4.63%
controls:2.05%
cases:16.67%
controls:9.83%
9
54
102
1056
—
—
—
—
5
22
103
1053
15
87
75
798
Leukocyte esterase [Presence] in Urine by Automated test strip
60026-2 [40763086]
3.8e-01
3.9e-01
—
—
—
2.3e-01
-1.2e+00
cases:9.91%
controls:7.03%
cases:5.36%
controls:3.68%
—
—
—
—
—
—
cases:4.63%
controls:3.72%
cases:5.56%
controls:15.93%
11
78
100
1032
6
41
106
1074
—
—
—
5
40
103
1035
5
141
85
744
Coloscopy
UJF32 [2001305029]
2.3e-01
-1.0e+50
—
—
—
—
-9.9e-02
cases:5.41%
controls:4.32%
cases:0.00%
controls:1.70%
—
—
—
—
—
—
—
—
cases:5.56%
controls:6.10%
6
48
105
1062
0
19
112
1096
—
—
—
—
5
54
85
831
amitriptyline; oral, parenteral
N06AA09 [21604696]
1.6e-01
—
—
—
-1.0e+50
—
1.9e-01
cases:4.50%
controls:3.87%
—
—
—
—
—
—
cases:0.00%
controls:0.54%
—
—
cases:5.56%
controls:4.63%
5
43
106
1067
—
—
—
0
6
112
1107
—
5
41
85
844
Three-surface restoration
SFA30 [2001310360]
-4.2e-01
8.1e-01
—
—
—
2.5e-01
6.9e-01
cases:5.41%
controls:8.02%
cases:6.25%
controls:2.87%
—
—
—
—
—
—
cases:5.56%
controls:4.37%
cases:23.33%
controls:13.22%
6
89
105
1021
7
32
105
1083
—
—
—
6
47
102
1028
21
117
69
768
Tinnitus
H93.1 [45543152]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.81%
—
—
—
—
—
—
—
—
—
—
—
—
0
9
111
1101
—
—
—
—
—
—
Snapping jaw
K07.60 [2000502791]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.79%
—
—
—
—
—
—
0
7
90
878
Dysuria/painful urination
U01 [2002001137]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.72%
—
—
—
—
—
—
—
—
—
—
—
—
0
8
111
1102
—
—
—
—
—
—
pivmecillinam; oral
J01CA08 [21602827]
5.2e-02
—
—
—
—
—
-2.0e-01
cases:9.91%
controls:9.46%
—
—
—
—
—
—
—
—
—
—
cases:8.89%
controls:10.62%
11
105
100
1005
—
—
—
—
—
8
94
82
791
Extraction of tooth
EBA00 [2001301923]
-8.5e-02
—
—
—
—
9.5e-01
1.5e-01
cases:5.41%
controls:5.86%
—
—
—
—
—
—
—
—
cases:5.56%
controls:2.23%
cases:12.22%
controls:10.73%
6
65
105
1045
—
—
—
—
6
24
102
1051
11
95
79
790
Implementation of physical therapy rehabilitation plan
SPAT1223 [2001700324]
2.1e-02
—
—
—
-1.0e+50
—
—
cases:4.50%
controls:4.41%
—
—
—
—
—
—
cases:0.00%
controls:0.45%
—
—
—
—
5
49
106
1061
—
—
—
0
5
112
1108
—
—
mirtazapine; oral
N06AX11 [21604740]
5.1e-01
6.3e-01
—
—
—
—
3.8e-01
cases:9.91%
controls:6.22%
cases:7.14%
controls:3.95%
—
—
—
—
—
—
—
—
cases:11.11%
controls:7.91%
11
69
100
1041
8
44
104
1071
—
—
—
—
10
70
80
815
Thyroxine (T4) free [Moles/volume] in Serum or Plasma
14920-3 [3008486]
3.0e-01
-2.6e-01
-1.0e+50
—
—
3.7e-01
2.4e-01
cases:18.02%
controls:13.96%
cases:6.25%
controls:7.98%
cases:0.00%
controls:0.81%
—
—
—
—
cases:13.89%
controls:10.05%
cases:36.67%
controls:31.19%
20
155
91
955
7
89
105
1026
0
9
112
1106
—
—
15
108
93
967
33
276
57
609
Remote monitoring CPAP
WX780 [2001310837]
-1.0e+50
-1.0e+50
—
—
—
—
—
cases:0.00%
controls:0.72%
cases:0.00%
controls:0.45%
—
—
—
—
—
—
—
—
—
—
0
8
111
1102
0
5
112
1110
—
—
—
—
—
Rehabilitation Hospital
283X00000X [38004285]
—
-1.0e+50
—
—
—
—
—
—
—
cases:0.00%
controls:0.45%
—
—
—
—
—
—
—
—
—
—
—
0
5
112
1110
—
—
—
—
—
Cystoscopy
UKC02 [2001306005]
8.0e-01
—
—
—
—
—
—
cases:4.50%
controls:2.07%
—
—
—
—
—
—
—
—
—
—
—
—
5
23
106
1087
—
—
—
—
—
—
Calcium.ionized [Moles/volume] in Venous blood
41645-3 [3033705]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:1.24%
—
—
—
—
—
—
0
11
90
874
Postmenopausal bleeding
N95.0 [45567872]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.68%
—
—
—
—
—
—
0
6
90
879
Prick test
37968009 [4242723]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.81%
—
—
—
—
—
—
—
—
—
—
—
—
0
9
111
1101
—
—
—
—
—
—
Urine symptom/complaint other
U07 [2002001142]
-1.0e+50
-1.0e+50
—
—
—
—
—
cases:0.00%
controls:0.54%
cases:0.00%
controls:0.54%
—
—
—
—
—
—
—
—
—
—
0
6
111
1104
0
6
112
1109
—
—
—
—
—
Sprain and strain of ribs and sternum
S23.4 [45534723]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.56%
—
—
—
—
—
—
0
5
90
880
Pathology report gross observation
24419-4 [3002256]
—
-1.0e+50
—
—
—
—
4.5e-01
—
—
cases:0.00%
controls:0.63%
—
—
—
—
—
—
—
—
cases:5.56%
controls:3.62%
—
0
7
112
1108
—
—
—
—
5
32
85
853
Own respiration
WX720 [2001310823]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.79%
—
—
—
—
—
—
0
7
90
878
Other medical or dental certificate
WZA90 [2001310883]
—
—
—
—
—
—
1.3e-01
—
—
—
—
—
—
—
—
—
—
—
—
cases:6.67%
controls:5.88%
—
—
—
—
—
—
6
52
84
833
loperamide; oral
A07DA03 [21600646]
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.56%
—
—
—
—
—
—
—
0
6
108
1069
—
Specialised imaging for glaucoma
CS5Z4 [2001301479]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.79%
—
—
—
—
—
—
0
7
90
878
Inguinal hernia
K40 [45543305]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.68%
—
—
—
—
—
—
0
6
90
879
Opening and preparing the root canals, complicated
SGA03 [2001310381]
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.65%
—
—
—
—
—
—
—
0
7
108
1068
—
Initiation and monitoring of IV fluid therapy
SPAT1083 [2001700184]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.54%
—
—
—
—
—
—
—
—
—
—
—
—
0
6
111
1104
—
—
—
—
—
—
loperamide oxide; oral
A07DA05 [21600648]
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.56%
—
—
—
—
—
—
—
0
6
108
1069
—
Paralysis/weakness
N18 [2002000729]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.56%
—
—
—
—
—
—
0
5
90
880
ciclesonide; inhalant
R03BA08 [21603291]
—
—
—
—
—
—
9.8e-01
—
—
—
—
—
—
—
—
—
—
—
—
cases:5.56%
controls:2.15%
—
—
—
—
—
—
5
19
85
866
Other synovitis and tenosynovitis
M65.8 [45582208]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.45%
—
—
—
—
—
—
—
—
—
—
—
—
0
5
111
1105
—
—
—
—
—
—
covid-19, RNA-based vaccine
J07BN01 [954934]
2.7e-01
-9.8e-02
-1.0e+50
—
—
2.8e-01
-3.0e-01
cases:18.02%
controls:14.32%
cases:8.04%
controls:8.79%
cases:0.00%
controls:0.90%
—
—
—
—
cases:7.41%
controls:5.67%
cases:12.22%
controls:15.82%
20
159
91
951
9
98
103
1017
0
10
112
1105
—
—
8
61
100
1014
11
140
79
745
Specific gravity of Urine by Test strip
5811-5 [3000330]
-1.0e+50
—
—
—
—
—
-1.0e+50
cases:0.00%
controls:0.45%
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:2.82%
0
5
111
1105
—
—
—
—
—
0
25
90
860
Dizziness and giddiness
R42 [45568132]
7.9e-01
—
—
—
—
—
8.8e-01
cases:5.41%
controls:2.52%
—
—
—
—
—
—
—
—
—
—
cases:10.00%
controls:4.41%
6
28
105
1082
—
—
—
—
—
9
39
81
846
Methemoglobin/Hemoglobin.total in Venous blood
2617-9 [3024889]
-1.0e+50
—
—
—
—
—
-1.0e+50
cases:0.00%
controls:0.54%
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:2.03%
0
6
111
1104
—
—
—
—
—
0
18
90
867
HIV 1 and 2 tests - Meaningful Use set
75622-1 [46235355]
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.93%
—
—
—
—
—
—
—
0
10
108
1065
—
fusidic acid; ointment
D06AX01 [21602062]
6.8e-01
—
—
—
—
—
7.2e-01
cases:4.50%
controls:2.34%
—
—
—
—
—
—
—
—
—
—
cases:8.89%
controls:4.52%
5
26
106
1084
—
—
—
—
—
8
40
82
845
Other specified special examinations
Z01.8 [45581003]
—
—
—
—
—
—
6.2e-01
—
—
—
—
—
—
—
—
—
—
—
—
cases:5.56%
controls:3.05%
—
—
—
—
—
—
5
27
85
858
Basic examination of mouth
SAA02 [2001310275]
-3.7e-01
-2.0e-01
—
—
-1.0e+50
6.0e-01
-3.5e-01
cases:12.61%
controls:17.30%
cases:6.25%
controls:7.53%
—
—
—
—
cases:0.00%
controls:0.54%
cases:11.11%
controls:6.42%
cases:20.00%
controls:26.21%
14
192
97
918
7
84
105
1031
—
—
0
6
112
1107
12
69
96
1006
18
232
72
653
macrogol; oral
A06AD15 [21600575]
—
-1.0e+50
-1.0e+50
—
—
-1.0e+50
7.4e-01
—
—
cases:0.00%
controls:0.81%
cases:0.00%
controls:0.54%
—
—
—
—
cases:0.00%
controls:1.12%
cases:6.67%
controls:3.28%
—
0
9
112
1106
0
6
112
1109
—
—
0
12
108
1063
6
29
84
856
Protein [Mass/volume] in Pleural fluid
2882-9 [3003434]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.56%
—
—
—
—
—
—
0
5
90
880
Hyperemia of pulp
K04.00 [2000502702]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.56%
—
—
—
—
—
—
0
5
90
880
citalopram; oral, parenteral
N06AB04 [21604712]
6.4e-01
—
—
—
—
—
5.5e-01
cases:6.31%
controls:3.42%
—
—
—
—
—
—
—
—
—
—
cases:5.56%
controls:3.28%
7
38
104
1072
—
—
—
—
—
5
29
85
856
chlorhexidine
S03AA04 [21605193]
8.0e-01
-1.0e+50
—
—
—
-1.0e+50
—
cases:4.50%
controls:2.07%
cases:0.00%
controls:0.90%
—
—
—
—
—
—
cases:0.00%
controls:0.74%
—
—
5
23
106
1087
0
10
112
1105
—
—
—
0
8
108
1067
—
Kolposcopy
ULA02 [2001306679]
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.56%
—
—
—
—
—
—
—
0
6
108
1069
—
brimonidine
S01GA07 [947915]
—
-1.0e+50
—
—
—
-1.0e+50
-1.0e+50
—
—
cases:0.00%
controls:0.63%
—
—
—
—
—
—
cases:0.00%
controls:0.56%
cases:0.00%
controls:0.79%
—
0
7
112
1108
—
—
—
0
6
108
1069
0
7
90
878
Benign neoplasm: Sigmoid colon
D12.5 [45552326]
—
-1.0e+50
—
—
—
—
—
—
—
cases:0.00%
controls:0.45%
—
—
—
—
—
—
—
—
—
—
—
0
5
112
1110
—
—
—
—
—
Geriatric Medicine
38 [38004478]
-1.0e+50
-1.0e+50
—
—
—
—
—
cases:0.00%
controls:0.54%
cases:0.00%
controls:0.45%
—
—
—
—
—
—
—
—
—
—
0
6
111
1104
0
5
112
1110
—
—
—
—
—
Presence of coronary angioplasty implant and graft
Z95.5 [45542496]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.72%
—
—
—
—
—
—
—
—
—
—
—
—
0
8
111
1102
—
—
—
—
—
—
Heartburn
R12 [45539318]
-1.0e+50
—
—
—
—
-1.0e+50
—
cases:0.00%
controls:0.54%
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.47%
—
—
0
6
111
1104
—
—
—
—
0
5
108
1070
—
Base excess in Arterial blood by calculation
1925-7 [3003396]
1.1e+00
-1.0e+50
—
—
—
—
1.4e+00
cases:5.41%
controls:1.80%
cases:0.00%
controls:0.45%
—
—
—
—
—
—
—
—
cases:10.00%
controls:2.71%
6
20
105
1090
0
5
112
1110
—
—
—
—
9
24
81
861
Spirometry study
18759-1 [3000492]
—
-1.0e+50
—
—
—
—
1.3e+00
—
—
cases:0.00%
controls:0.81%
—
—
—
—
—
—
—
—
cases:7.78%
controls:2.26%
—
0
9
112
1106
—
—
—
—
7
20
83
865

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
35
106
4.26
10.75
1.9
2.2
31.31
31.45
u/l
0.01
29
83
58
263
3.35
9.61
7.8
4.5
—
—
—
0
0
43
168
3.44
8.97
3.4
3.1
3.57
2.67
e6/l
0.22
21
81
72
413
2.88
7.31
2.8
2.0
84.82
95.93
pmol/l
1.29
39
205
54
272
2.80
6.95
2.8
2.1
2.71
2.76
mg/l
0.05
46
238
64
352
2.77
6.94
3.5
3.2
18.62
218.11
e6/l
0.56
41
269
69
401
2.72
6.62
4.7
3.8
84.78
66.15
e6/l
0.15
41
278
59
328
2.58
6.05
5.8
3.9
7.39
7.40
ph
0.03
40
240
22
71
3.57
5.98
2.1
2.2
—
—
—
0
0
56
313
2.49
5.57
3.6
3.0
1.10
0.46
e6/l
0.52
34
230
28
113
2.93
5.28
12.7
12.2
7.42
7.42
ph
0.10
16
72
53
296
2.43
5.20
4.8
2.4
—
—
—
0
0
25
96
3.03
5.13
15.6
9.2
—
—
—
0
0
91
666
2.56
4.61
5.7
4.3
—
64.08
—
0
12
30
135
2.63
4.57
2.1
2.5
—
—
—
0
0
59
362
2.25
4.50
7.9
6.5
—
—
—
0
0
36
179
2.45
4.46
3.4
2.6
2.49
2.45
mmol/l
0.95
31
153
53
313
2.25
4.42
2.6
2.9
—
0.29
—
0
7
30
138
2.57
4.36
1.5
1.6
—
—
—
0
0
52
306
2.24
4.36
2.1
2.1
264.89
213.68
u/l
0.23
47
296
79
552
2.28
4.32
8.2
6.8
0.60
0.58
e9/l
0.40
67
486
80
564
2.28
4.25
8.2
6.9
1.72
1.91
e9/l
0.89
68
509
27
120
2.62
4.20
2.4
1.8
—
—
—
0
0
80
566
2.26
4.19
9.4
7.3
0.20
0.20
e9/l
0.01
69
503
52
313
2.17
4.07
3.7
2.8
—
—
—
0
0
78
552
2.20
4.00
8.3
6.8
0.04
0.04
e9/l
0.68
66
482
33
165
2.38
4.00
2.8
2.2
9.57
14.17
umol/l
2.32
28
154
20
78
2.88
3.96
8.0
9.7
24.39
24.90
mmol/l
0.20
20
78
19
72
2.95
3.96
3.8
2.4
385.74
175.63
ng/l
1.40
19
66
30
145
2.43
3.91
2.8
2.2
20.65
23.96
%
0.39
25
135
65
440
2.05
3.62
3.9
2.8
—
—
estimate
—
0
0
20
82
2.73
3.61
1.6
3.5
0.20
0.21
g/l
0.23
20
74
83
621
2.11
3.44
14.5
10.3
4.32
4.04
e9/l
0.48
74
549
48
296
2.04
3.41
2.0
1.7
20.26
21.37
nmol/l
0.15
43
250
70
496
2.00
3.34
10.0
11.7
0.00
0.00
e9/l
0.49
56
403
105
874
2.71
3.22
38.0
19.3
14.15
13.61
%
2.37
105
863
16
65
2.69
2.93
18.9
10.5
94.29
92.68
%
0.69
16
65
80
610
1.95
2.91
7.9
5.8
7.48
6.52
mmol/l
2.54
74
570
7
14
5.24
2.77
1.1
1.1
—
—
—
0
0
41
257
1.91
2.68
3.9
3.1
351.63
343.37
umol/l
0.16
32
224
27
146
2.10
2.65
13.9
8.0
104.48
104.34
mmol/l
0.05
27
146
64
463
1.83
2.65
2.9
3.2
6.34
6.20
ph
0.34
22
249
37
228
1.90
2.52
2.0
1.9
1.76
1.45
mg/l
0.24
29
186
28
157
2.02
2.50
1.4
1.7
756.48
1226.29
nmol/l
3.04
21
126
11
38
3.08
2.49
1.8
1.1
—
—
—
0
0
62
451
1.78
2.47
36.1
13.5
1.55
1.22
inr
3.31
50
376
18
87
2.26
2.31
1.8
4.5
91.00
73.07
e9/l
—
10
72
110
987
2.51
2.24
28.5
15.5
30.98
22.89
mg/l
1.69
99
786
11
42
2.78
2.21
2.1
1.6
—
5.23
—
0
7
107
940
2.37
2.18
5.9
5.2
1.78
1.90
mu/l
0.49
102
855
49
343
1.73
2.16
8.7
6.7
—
—
—
0
0
23
127
2.01
2.13
7.3
5.1
7.36
7.39
ph
1.46
18
80
8
27
3.10
1.97
1.0
1.1
—
—
—
0
0
29
179
1.82
1.93
4.1
4.1
0.77
0.81
mmol/l
1.18
29
168
8
28
2.99
1.90
1.1
1.2
—
—
—
0
0
6
18
3.45
1.77
2.7
2.6
18.92
13.32
mg/l
—
6
18
47
340
1.63
1.77
4.4
3.2
6.66
7.93
mmol/l
0.88
42
290
13
62
2.23
1.73
7.2
11.6
—
—
—
0
0
112
1034
2.41
1.71
19.6
13.7
—
—
—
0
0
5
14
3.68
1.63
1.6
4.6
408.40
746.21
mg
—
5
14
20
319
0.55
1.63
3.9
3.7
0.00
0.00
estimate
—
10
112
41
294
1.60
1.57
1.5
1.4
2.10
1.81
u/ml
—
5
63
26
382
0.59
1.55
2.5
3.2
—
—
—
0
0
5
15
3.43
1.54
2.6
1.4
—
—
—
0
0
20
118
1.84
1.53
1.2
1.2
—
—
—
0
0
31
432
0.62
1.48
3.5
3.6
0.00
0.00
estimate
—
9
107
71
583
1.54
1.47
3.2
3.7
0.00
0.00
estimate
-0.00
11
113
36
256
1.58
1.41
1.5
1.5
2.12
2.39
g/l
0.34
15
138
5
17
3.02
1.37
1.0
1.0
—
—
—
0
0
104
945
1.80
1.30
4.3
4.9
1.39
1.45
mmol/l
0.71
91
868
31
217
1.58
1.29
2.5
2.8
567.12
543.38
mosm/kgh2o
0.19
25
190
106
969
1.86
1.29
5.8
5.6
2.52
2.63
mmol/l
0.62
99
894
69
573
1.49
1.29
3.2
3.6
0.00
0.00
estimate
-0.00
11
124
17
101
1.80
1.28
1.4
1.5
—
—
—
0
0
26
175
1.62
1.27
1.6
1.7
—
—
—
0
0
104
949
1.76
1.23
4.5
4.9
4.36
4.53
mmol/l
0.97
92
881
69
578
1.46
1.20
3.2
3.6
0.00
0.00
estimate
-0.00
11
125
38
283
1.50
1.20
1.4
1.4
—
—
—
0
0
28
196
1.56
1.16
2.5
3.1
1.51
0.77
ug/l
0.29
13
130
7
33
2.19
1.07
1.3
3.1
—
—
—
0
0
21
140
1.61
1.07
2.7
2.0
96.33
105.74
ug/g
0.08
15
104
21
140
1.61
1.07
1.3
1.2
—
—
—
0
0
48
386
1.41
1.00
2.4
2.1
—
—
—
0
0
20
134
1.59
1.00
1.4
1.6
—
—
—
0
0
86
771
1.42
0.90
4.9
4.4
14.71
14.86
pmol/l
0.23
80
702
27
199
1.46
0.89
2.0
2.2
—
—
—
0
0
98
902
1.49
0.87
3.9
4.2
1.30
1.26
mmol/l
0.26
85
824
26
194
1.44
0.80
1.3
1.3
15.54
32.68
iu/ml
—
8
68
39
316
1.35
0.75
5.0
3.3
125.58
62.03
mg/l
0.45
27
213
7
39
1.84
0.74
1.0
1.5
—
—
—
0
0
27
339
0.74
0.67
2.4
3.7
—
—
—
0
0
8
50
1.64
0.63
1.0
1.1
—
—
—
0
0
8
50
1.64
0.63
1.4
1.2
—
—
—
0
0
0
20
0.00
0.61
0.0
1.1
—
—
—
0
0
0
20
0.00
0.61
0.0
1.1
—
—
—
0
0
25
313
0.75
0.60
3.0
3.5
0.00
0.00
estimate
—
10
104
39
326
1.29
0.59
6.6
3.8
26.67
11.07
mg/mmol
0.46
26
207
6
35
1.75
0.58
1.2
1.6
12.88
11.95
u/l
—
6
26
100
946
1.36
0.54
5.4
5.0
6.24
5.96
mmol/l
0.80
94
858
12
84
1.48
0.51
1.2
1.5
—
—
—
0
0
20
253
0.75
0.51
3.3
3.4
1.02
1.02
kg/l
0.10
13
152
7
45
1.59
0.50
1.6
2.4
—
—
—
0
0
7
45
1.59
0.50
1.6
2.4
—
—
—
0
0
7
46
1.55
0.49
1.6
2.3
—
—
—
0
0
7
46
1.55
0.49
1.6
2.3
—
—
—
0
0
7
46
1.55
0.49
1.6
2.3
—
—
—
0
0
29
242
1.26
0.44
2.6
2.6
9.47
5.49
e6/l
0.27
24
220
0
15
0.00
0.41
0.0
2.7
—
3.17
—
0
15
0
15
0.00
0.41
0.0
1.5
—
—
—
0
0
0
17
0.00
0.41
0.0
1.6
—
—
—
0
0
0
17
0.00
0.41
0.0
2.6
—
4.05
—
0
17
0
17
0.00
0.41
0.0
2.6
—
105.82
—
0
17
0
17
0.00
0.41
0.0
2.6
—
1.19
—
0
17
5
34
1.49
0.41
5.6
2.1
0.20
0.22
g/l
—
5
34
5
34
1.49
0.41
6.0
2.1
1.11
1.14
g/l
—
5
34
0
18
0.00
0.40
0.0
2.9
—
13.02
—
0
18
21
254
0.79
0.39
5.6
5.1
—
—
—
0
0
10
134
0.72
0.37
1.5
1.7
—
—
—
0
0
37
325
1.20
0.36
3.5
5.7
8.83
2.06
ug/l
0.41
32
287
7
52
1.37
0.32
13.3
3.9
37.04
36.98
°c
—
7
52
14
111
1.30
0.31
1.5
1.3
—
—
—
0
0
8
62
1.31
0.29
1.0
1.2
—
—
—
0
0
7
95
0.72
0.23
4.1
3.6
—
—
—
0
0
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
0
12
0.00
0.21
0.0
15.6
—
9.98
—
0
12
0
12
0.00
0.21
0.0
1.4
—
—
—
0
0
0
12
0.00
0.21
0.0
2.0
—
—
—
0
0
0
13
0.00
0.21
0.0
3.3
—
32.08
—
0
13
12
104
1.17
0.13
1.3
1.9
—
—
—
0
0
14
124
1.15
0.12
1.4
1.3
—
—
—
0
0
6
53
1.14
0.09
4.5
2.1
47.77
60.01
u/ml
—
6
53
6
53
1.14
0.09
1.0
1.3
—
—
—
0
0
7
82
0.84
0.07
2.6
3.8
1.21
1.22
mmol/l
—
7
71
41
400
1.04
0.03
2.8
4.1
37.12
38.90
ng/l
0.04
19
288
20
205
0.97
0.00
1.5
1.8
479.93
65730809.88
pmol/l
0.50
15
178
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
0
5
0.00
0.00
0.0
1.2
—
156.00
—
0
5
0
5
0.00
0.00
0.0
1.4
—
0.21
—
0
5
0
5
0.00
0.00
0.0
2.8
—
1820.00
—
0
5
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
168.67
—
0
6
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
7
0.00
-0.00
0.0
2.4
—
2.19
—
0
7
8
84
0.95
-0.00
1.4
1.3
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
8
0.00
-0.00
0.0
2.0
—
9.14
—
0
8
0
8
0.00
-0.00
0.0
2.4
—
5.89
—
0
8
0
8
0.00
-0.00
0.0
1.4
—
7.91
—
0
8
0
7
0.00
-0.00
0.0
1.9
—
15.41
—
0
7

Mortality – FinRegistry

↥

This endpoint is excluded (different definition than used in FinnGen).

Relationships between endpoints

↥

Index endpoint: Q17_OTHER_CONGEN_MALFO_INTEG_WIDE – Other congenital malformations of integument, including avohilmo

GWS hits: -

This endpoint is excluded (different definition than used in FinnGen).